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Coolmine marks 40 years in 
addiction services
Coolmine Therapeutic Community in Co Dublin celebrated 40 years in service delivery on 
Friday 17 May. A commemorative event was held at Coolmine Lodge to mark the occasion 
and a book aptly entitled 40 years helping people find their way home was launched, which 
includes a collection of stories from past Coolmine clients. Established in 1973, Coolmine was 
the first specialist drug treatment centre of its kind in the country.
Coolmine’s mission is to provide a 
range of quality community and 
residential services to empower people 
to end their dependence on drugs 
and alcohol. The continuum of care 
services range from detoxification 
through to lifelong aftercare, and 
include: outreach services; drop in 
services (where clients contemplating 
a drug free life can initially seek help/
advice); stabilisation programmes; day 
programmes; residential programmes 
(including the only mother and child 
residential programme in the country); 
educational programmes; and 
community employment. 
The treatment approach is based 
on peer support, in which drug-free participants, who live in small, structured, drug-free 
housing, are expected to contribute to the general running of the community and to their 
own recovery by actively taking part in educational activities and in group and individual 
therapy sessions.
Following some emotive and inspiring stories from current and past clients of Coolmine, 
CEO Pauline McKeown gave a brief overview of the community’s vision and goals. She said 
that Coolmine currently provides a range of addiction treatment services to approximately 
1,000 people each year. Ms McKeown highlighted some recent changes in the type of clients 
presenting to the centre, namely the increasing age profile (majority are in their thirties) 
and the move from predominantly Dublin admissions to over 50% of all admissions now 
coming from outside the capital. She also pointed to trends away from use of single opiates to 
polydrug use, and to a growth in the numbers taking cocaine, crack, and benzodiazepine. 
The event was attended by President Michael D Higgins, who held the large audience captive 
with his praise for the services offered by Coolmine over the past 40 years. In particular, he 
mentioned the knock-on effects of addiction on families and friends, who he said were also 
beneficiaries of the success achieved through Coolmine’s programmes. He reiterated the 
importance of Coolmine’s work in providing a safe haven for people with addictions, who he 
felt generally get very little sympathy from the wider society. Also in attendance were founder 
Lord Paddy Rossmore and the children of the other founders, Jackie Ballard and Brian Delaney. 
Special guest speaker for the graduation was Mr Rowdy Yates, Senior Research Fellow at the 
University of Stirling.
The event culminated with a tour of the facilities and the graduation of the most recent clients 
to successfully complete Coolmine’s programme. 
(Caraíosa Kelly)
President Michael D Higgins with Coolmine 
Chairman Brian Ward and CEO Pauline McKeown  
at the 40-year celebratory event.
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2contents Responding to addiction  
in a time of recession –  
BYAP seminar
Brian Harvey, having outlined the scale of the 
withdrawal of resources from community-
led responses to poverty and social inclusion, 
particularly since 2002, echoed the sense 
among those present that no one could have 
anticipated the wave of destruction of our social, 
community development infrastructure that we 
are experiencing, when Ireland was previously 
seen as a European leader in this regard. He 
outlined what he termed a ‘strategic turn’ which 
began in 2002 and which was compounded 
by the 2008 economic and social crisis. Against 
a baseline figure of a 4.3% cut in government 
spending overall between 2008 and 2013, local 
and community development programmes 
have been cut by 42%, and the Drugs Initiative 
by 32%. It is estimated that by 2015, there will 
be 31% fewer workers in the voluntary and 
community sector. Mr Harvey added that no 
other country in Europe, so far as we know,  
has experienced such an extraordinary decline 
since 1948. 
Dr Mary Ellen McCann illustrated the intimate 
connection between community issues and drug 
problems, and how policies in either domain 
have large effects in other domains. In the 
context of competing consultancy reports, the 
call for ‘evidence’ needs to take account of a 
range of more subtle measures, including case 
studies which provide rich data to increase our 
understanding, and the utilisation of community 
indicators that allow access to a range of 
measures regarding what is really important 
for communities affected by drug use. She 
stressed that, in the context of the narrative of 
the development of community responses, the 
community needs to tell the community story. 
Underlying the recognition of the current crisis 
and its origins, contributors were clearly wary of 
the talk of a straightforward recovery, where ‘all 
will be well again’. Instead, the speakers raised 
the real concern of ‘cost cutting’ becoming 
‘penny pinching’ in the name of ‘reform’, and 
the growing hints of ‘post-austerity austerity’. 
A clear message was given regarding the 
importance of holding on to the developments 
within the sector that have been achieved over 
the last 30 years, and the ‘footholds that have 
been gained’ in the creation of community 
responses and systems. The response within the 
voluntary and community sector must endure 
and, as Mr Harvey concluded, ‘It behoves  
us to make the case for an enlightened  
balanced European social model, with a role  
for civil society’.
(Brigid Pike and Dermot King)
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On 24 June 2013 the Ballymun Youth Action 
Project (BYAP) hosted a seminar on responding 
to addiction in a time of recession. The purpose 
of the seminar was to provide an opportunity 
to step back and think about the experience 
of the impact of funding cutbacks, and the 
implications for this particular sector. Róisín 
Shortall TD described the seminar as providing 
a ‘critical space’ to reflect on what amounts to a 
slow dismantling of the safety net that has been 
created within local communities, leading to the 
re-marginalisation of particular areas. 
The seminar was attended by over 80 
representatives of community and voluntary 
agencies, funders, local people and political 
representatives. There were two speakers – 
Brian Harvey, an independent social research 
consultant, and Dr Mary Ellen McCann, 
lecturer in UCD’s School of Applied Social 
Science and former director of Ballymun Youth 
Action Project.
Dermot King, executive director of BYAP, 
outlines the key themes that emerged at 
the seminar.
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potential for change
Founded in 1981, the Ballymun Youth Action Project (BYAP) is a community-based response to drug and alcohol misuse. It 
works with individuals, supports families and communities, and builds capacity through training and research. At its seminar 
on austerity, described in a separate item in this issue of Drugnet Ireland, BYAP invited Róisín Shortall TD, former Minister of 
State with responsibility for drugs, to launch its annual report for 2012 and its strategic plan for 2013–2015.1 
In 2012 BYAP provided services to well over 1,000 people, as the following selection from the annual report shows.
Service provided, 2012 Number of recipients/participants
Individual services, ranging from contact services delivered to those not  
engaged with services, through day programmes, counselling, family  
services, complimentary services, to aftercare services for those in recovery
 
 
567
Schools Drug and Alcohol Awareness Programme, delivered in five local  
primary schools
 
230
Boxing Clever Programme 22
Drug Treatment Programme in Mountjoy Prison 72
URRUS (Education and Training Services) 550
URRUS (Education and Training Services) 300
Source: BYAP Annual report 2012
BYAP also collaborated with other local groups in the delivery of services, including the Ballymun Educational Support Team 
(BEST), the Ballymun Regional Youth Resource (BRYR), Youthreach Ballymun, and the Community and Family Training Agency 
(CAFTA).
In 2012 BYAP lost its funding from the City of Dublin Youth Services Board (CDYSB),2 which opted to redirect funds to 
‘mainstream youth services’, and had to make two staff members redundant and reduce the working hours of 10 others as a 
direct result of cutbacks. However, BYAP continued to evolve to meet local needs, becoming part of the Community Detox 
Pilot Programme, participating in the Network for Assisting Children and Young People (NACYP), and creating a new position 
of ‘infant parent support worker’, which is funded by the Ballymun LDTF. The aim of this new role is to meet the needs of 
children and parents where there are issues related to problem drug and/or alcohol use in the infant stages of the child’s life. 
Finally, in 2012 BYAP began using the eCASS (electronic Consolidated Automated Support System) data system and reported 
that it became much easier to monitor and report on work done. It plans to develop eCASS further in the coming years, to 
maximise effectiveness of interventions and capture outcomes.
In its strategic plan for 2013–2015, BYAP sets out its way 
of working. Its approach is rooted in an ethos of valuing 
individuality and the capacity of individuals, families and 
communities. It commits to: 
 ■  respecting where people have come from, where they 
are at now, and where they see they could be;
 ■  supporting the possibility of change; and
 ■  addressing where necessary the bigger issues that are 
presented by the many cross-cutting systems within 
which each individual has to make their way in life, 
including their family, the education system, the justice 
system, and the health system.
These values and commitments are reflected in the  
three strategic objectives and actions that BYAP has set for 
the next three years, which are summarised in the table on 
the following page. 
(Brigid Pike)
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1.  To provide a continuum of service which 
meets people where they are at, provides 
a range of treatment and rehabilitation 
pathways that are flexible and effective, 
and which works in conjunction with the 
range of other services locally.
-  Communicate BYAP’s vision to all stakeholders to maximise  
positive outcomes
-  Establish BYAP’s role as a provider within the developing profile of 
addiction services in Dublin North-East
-  Roll out an interagency data sharing system in partnership with the 
Ballymun LDTF
2.  To identify emerging trends within 
drug and alcohol use, and to develop 
appropriate responses
-  Develop services for young people through engaging with young 
polydrug users, and engaging with the NACYP
-  Promote a detailed presentation of BYAP services for young people  
with drug and alcohol issues
-  Engage with Dept of Justice as it expands initiatives supporting 
reintegration of prisoners into the community
-  Promote a detailed presentation of BYAP services for family members 
affected by drug or alcohol use
3.  To promote and acknowledge change as an 
integral part of the response to drug and 
alcohol use
-  Review the needs of the ageing opiate-using population who are 
currently using BYAP services
-  Develop new treatment/rehabilitation interventions for this population 
at individual and group level
-  Develop and deliver specific programmes that respond to change-
related challenges facing service users
Source: BYAP Strategic plan 2013–2015
1. Ballymun Youth Action Project (2013) Annual report 2012. Dublin: The Ballymun Youth Action Project Ltd, and Ballymun Youth 
Action Project (2013) Strategic plan 2013–2015. Dublin: The Ballymun Youth Action Project Ltd. www.drugsandalcohol.ie/20081 
2. The CDYSB is the youth development agency of the City of Dublin Education and Training Board (CDETB), formerly the City of 
Dublin Vocational Education Committee.
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5Extent and patterns of cannabis use  
in Ireland
The National Advisory Committee on Drugs and Alcohol 
(NACDA) recently published Bulletin 3 in the series of 
reports on the 2010/11 survey on drug use in the general 
population in Ireland and Northern Ireland.1 The bulletin 
reports on cannabis use in the adult population (15–64 
years), on cannabis dependence and cannabis abuse as well 
as on patterns of cannabis use in Ireland. A total of 5,128 
people were interviewed, representing a response rate of 
60%. This article presents a summary of the main results for 
Ireland reported in the bulletin.
Key findings
Prevalence: use, abuse and dependence
The results from the 2010/11 survey reveal that 25% of the 
adult population (15–64 yrs) reported having used cannabis 
at some point during their lives (lifetime use); 6% reported 
use in the year prior to the survey (recent use); 3% reported 
use in the month prior to the survey (current use). 
The rates of cannabis use were notably higher among 
men than women. Lifetime prevalence for men (33%) was 
almost twice as high as the rate for women (18%); last-year 
prevalence was three times as high (men, 9% vs women, 
3%); and last-month prevalence was five times as high  
(5% vs 1%). The lifetime prevalence among men increased 
from 27% in the 2006/7 survey to 33% in the 2010/11 
survey, a statistically significant increase of 22%. There was 
a relatively small increase, from 17% to 17.5%, in women’s 
lifetime prevalence rates in the same period.
Rates of cannabis use were substantially higher among 
young adults (15–34 years) than among older adults  
(35–64 years) in the 2010/11 survey. Lifetime prevalence 
among young adults (33%) was more than one and a half 
times that among older adults (19%), last-year prevalence 
was just over three times as high (young adults 10% vs 
older adults 3%) and last-month prevalence was five times 
as high (5% vs 1%). While there were statistically significant 
increases in lifetime prevalence for younger adults, 
from 29% in 2006/7 to 33% in 2010/11, no statistically 
significant changes were found for older adults over that 
period (3% in both 2006/7 and 2010/11). 
The prevalence of cannabis abuse and of cannabis 
dependence were measured in the NACD Drug Prevalence 
Survey the first time in 2010/11 using M-CIDI,2 as advised 
by the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). Substance abuse and substance 
dependence are defined by the DSM-IV as a maladaptive 
pattern of substance use leading to clinically significant 
impairment or distress. 
Seventeen per cent of recent cannabis users met the 
criteria for cannabis abuse, with rates being higher among 
males (20%) than females (8%) and among young adults 
(20%) than older adults (9%). Of the valid responses 
from the survey sample, 1.3% met the criteria for current 
cannabis abuse. Applying this rate to the 15–64-year-old 
general population (3,073,269 in 2011) we can infer that 
approximately 39,953 people in Ireland abuse cannabis. 
Nine per cent of recent cannabis users were classified as 
dependent. Dependence was higher among males and 
among young adults. Of the valid responses from the 
survey sample, 0.6% met the criteria for current cannabis 
dependence. Applying this rate to the 15–64-year-old 
general population, we can infer that approximately 18,440 
people in Ireland are cannabis dependent. 
Patterns of cannabis use
Among lifetime cannabis users, the median age of first use 
was 18 years. This was unchanged since the last survey. 
Almost half (48%) of the current cannabis users had used 
cannabis on 1–3 days (lowest frequency use) in the month 
prior to the survey, an increase on the 2006/7 figure of 
37%; this frequency was most common among female 
users (54%) and older adult users (55%). Between the two 
surveys the proportion of all adults engaging in the highest 
frequency use (20 days or more) in the previous month 
decreased from 24% to 14%.
Since 2006/7 the relative share of herb to resin used by 
current users has reversed. In 2010/11 herb was the main 
type of cannabis used by current users, at 71%, while resin, 
at 60%, was the most common form reported in the 2006/7 
survey. Almost all (94%) current cannabis users said that 
a joint was the main method they used when consuming 
cannabis. Forty-five per cent did not know where the 
cannabis they consumed was grown; 38% said that the 
cannabis they used was grown in Ireland, an increase on the 
2006/7 figure of 16%. 
Nearly three quarters (73%) of recent users said it would be 
easy for them to obtain cannabis in a given 24-hour period. 
Over four fifths (83%) said they sourced cannabis from 
someone they knew relatively well, e.g. either shared by or 
bought from family members and/or friends. 
Over one quarter (27%) of lifetime cannabis users said  
they had used it on a regular basis at some point and most 
(74%) of this group said they had stopped using. The three 
most common reasons given for stopping cannabis use 
were: not wanting to take it any more (27%); cannabis 
being no longer a part of their social life (18%); and health 
concerns (17%).
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6Acceptability of cannabis use
Respondents were asked about the acceptability and risk of 
cannabis use: 
 ■ 66% agreed with cannabis use being permitted for 
medical reasons; 
 ■ 69% disagreed with cannabis use being permitted for 
recreational reasons; 
 ■ 73% disapproved of smoking cannabis occasionally; 
 ■ 64% considered smoking cannabis on a regular basis to 
be very risky.
Profile of cannabis users in Ireland
Socio-economic group: Rates for lifetime cannabis use were 
highest among those classified as Group A (professionals 
and managers) (35%) and lowest among those in Group D 
(semi-skilled and un-skilled) (20%). Last-year rates were also 
highest for those in Group A (10%) and lowest among those 
in Group C2 (skilled manual workers) (7%). 
Housing tenure: Cannabis prevalence rates were highest 
among people renting accommodation. Among those 
renting from a private landlord, the lifetime prevalence rate 
was 37%, and last-year prevalence was 12%. Rates for  
last-month use were highest among those renting from a 
local authority/housing agency (7%). 
Level of education and age left school: Results point to 
cannabis use increasing with level of education attained.  
On the one hand, rates were highest among students, 
at 21% (lifetime), 10% (last-year) and 4% (last-month). 
Lifetime rates were also highest among those who had 
left school at 20 years or over (34%) and among those 
with a third-level education (31%). On the other hand, 
lowest lifetime rates were found for those who left school 
at 15 years or under and among those with primary-level 
education only (19%). 
Marital status: Last-year prevalence was highest among 
those who were cohabiting (13%), followed by those who 
were single (12%). Last-month rates were highest among 
cohabiting and divorced people (at 7%). 
Discussion
The findings of the 2010/11 survey suggest a mixed  
picture regarding the cannabis situation in the general 
population in Ireland. More people than ever before had 
tried cannabis at least once in their lifetime, with the rate 
at one in four adults, compared to one in six in the 2002/3 
survey. The trend is, however, changing and rates for last-
year and last-month prevalence have tapered off since the 
last survey. This development is in line with that in many 
European countries which are reporting a recent fall or 
stabilisation in cannabis prevalence rates.3 Additionally, 
among those consuming cannabis, age of initial use has 
remained the same, a welcome finding given the link 
between early initiation and high-risk groups. 
The 2010/11 survey data show that age continues to be  
an important factor in the pattern of cannabis use in Ireland 
and that use declines with age. Gender is also important 
for several reasons: it interacts with age with the effect that 
the decline in use happens later for men than for women. 
Although the extent of use has declined, prevalence rates 
are still considerably higher among men than women, with 
no indication of any narrowing of the gender gap. Closer 
examination of the data is needed, however, as these age 
and gender effects are likely to vary across regions in Ireland, 
reflecting differences in context, particularly social and 
economic circumstances. These influences, how they vary 
with context and time are important, particularly for 
targeting areas where patterns of drug use have become 
entrenched and for identifying where action may be needed 
to prevent this situation. 
When compared to results from the 2006/7 survey, 
cannabis is now used less frequently among current users, 
an important finding given the increased uptake of herbal 
cannabis use since the last survey. While the data from the 
two surveys show that high-frequency use has always been 
more common among men than women, the propensity for 
men to be high-frequency users has fallen sharply since the 
2006/7 survey, with the effect that the gap between men 
and women has reduced considerably between the two  
time periods. 
The likelihood of a young adult in Ireland using cannabis 
daily or almost daily has declined substantially since the 
survey in 2006/7. Despite lower prevalence, frequency of 
use is higher among older adults, changing little since the 
last survey. Among current users, high-frequency use, or 
intensive use, is reported by 10% of young adults and 24% 
of older adults. 
An indication of the public health impact of a drug can be 
seen in the numbers entering treatment. The number of 
treatment cases reporting cannabis as their main problem 
substance has increased significantly in Ireland and in 2010 
cannabis became the most common problem drug reported 
by new cases.4 
Dependence is increasingly recognised as a possible 
consequence of regular cannabis use. For many people, 
intensive use and dependence on cannabis are linked. 
Among those defined as recent users, 17% met the 
EMCDDA criteria for cannabis abuse and 9% were classified 
as dependent.
However, in comparison with the available data on tobacco 
or alcohol use, little is known about the extent of cannabis 
dependence or abuse in Ireland. This bulletin provides a 
solid baseline for the ongoing monitoring of the prevalence 
and nature of cannabis dependence and abuse in the 
general population and among recent users. Its findings also 
point to the need for further research on the consequences 
of increased availability of high-potency cannabis, on the 
experiences of cannabis use in the population of long-term 
users, and on the continuation and discontinuation rates of 
long-term use and factors influencing these rates and how 
these might be targeted by treatment and other services. 
(Justine Horgan)
1. National Advisory Committee on Drugs (2013) Drug use in 
Ireland and Northern Ireland. 2010/11 Drug prevlence survey: 
cannabis results. Bulletin 3. Dublin: Stationery Office. www.
drugsandalcohol.ie/20139
2. The Composite International Diagnostic Interview (CIDI, 
World Health Organization, 1990) contains the DSM-IV 
diagnostic criteria for substance abuse and dependence 
and is a validated method to assess the seriousness of a 
person’s cannabis use. On the advice of the EMCDDA, the 
abbreviated version, the Munich Composite International 
Diagnostic Interview (M-CIDI), a 19-item instrument 
reflecting the four cannabis abuse and seven cannabis 
dependence criteria, was used for the NACD 2010/11  
Drug Prevalence Survey.
3. EMCDDA (2011) Annual report 2011:the state of the  
drugs problem in Europe. Luxembourg: Publications Office of 
the European Union. www.drugsandalcohol.ie/16288
4. Bellerose D, Carew AM and Lyons S (2011) Trends in  
treated problem drug use in Ireland 2005–2010. HRB  
Trends Series 12. Dublin: Health Research Board.  
www.drugsandalcohol.ie/16381
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7Criminalising addiction: is there  
another way? 
This was the title of a conference hosted by CityWide Drugs 
Crisis Campaign in Dublin on 21 May 2013. The objective 
was to start an evidence-based debate on Ireland’s current 
drug policies and the alternatives.1
Some 120 participants from community drug projects, 
voluntary projects, youth services, drugs task forces, 
government departments and universities attended the 
conference at which four speakers made presentations – 
Brigid Pike, Health Research Board (HRB); Liam Herrick, Irish 
Penal Reform Trust (IPRT); Johnny Connolly, HRB; and Niamh 
Eastwood, Release. Brief reports on these presentations are 
provided in the following pages.2
Following the presentations, participants took part in table 
discussions on the barriers to decriminalisation and what the 
international evidence tells us about the issue. There was 
general, but not complete, agreement that the evidence 
for decriminalisation is convincing, while the issues around 
legalisation appear to be complicated. It was also noted that 
the underlying issues of poverty and social disadvantage 
remain crucial to addressing the impact of drugs on the lives 
of people, families and communities. 
In closing the conference, the chairperson of CityWide, Anna 
Quigley, stated that the conference was a first step. CityWide 
plans further steps to promote the debate. 
1. The conference was organised on foot of a commitment 
made by CityWide in 2012 to hold an open debate on 
decriminalisation. See Higgins M (2012) The drugs crisis:  
a new agenda for action. Dublin: CityWide.  
www.drugsandalcohol.ie/17145 
2. A written report on the conference and videos  
of the four presentations are available at  
www.citywide.ie/news/2013/05/27
Breaking the taboo – debating the 
alternatives to criminalised addiction
The first presenter at the CityWide conference, Brigid Pike (HRB), described how calls have been coming thick and  
fast from around the world since 2009 to ‘break the taboo’ on debating alternatives to the international drug prohibition 
regime.1 
In December 2012 the UN General Assembly adopted a resolution to hold a Special Session (UNGASS) on the  
world drug problem in 2016. The sponsors of the resolution noted that
…despite continuing increased efforts by States, relevant organisations, civil society and non-governmental organisations, 
the world drug problem continues to constitute a serious threat to public health and safety and the well-being of 
humanity, in particular children and young people and their families, and to the national security and sovereignty of 
States, and that it undermines socioeconomic and political stability and sustainable development. 
Posing the questions, what is Ireland’s policy position going to be at this Special Session, how will it arrive at this position 
and how open will the process be, Pike proposed a model for thinking about democratic processes in relation to drug policy 
development (see graphic below). Drawing on the work of cultural sociologist Jeffery Alexander,2 she suggested that a range 
of different actors need to participate fully to ensure open and public debate: 
drugnet>
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8Politicians, civil society organisations, government ministers, 
political parties, policy advisers and officials, and the media  
all need to contribute to the debate. While there is evidence 
that individual politicians have become more open in recent  
years to exploring alternative responses to the illicit drug 
problem,3 there is room for a more systematic and concerted 
effort by all parties. 
The debate needs to be informed by theory, research-
based evidence and analysis of the consequences, risks 
and benefits of the various policy options. While Ireland 
has made enormous strides with regard to the collection 
of data on the extent and nature of drug misuse in Ireland, 
and on interventions, Pike noted that there has never 
been an evaluation of Ireland’s national drugs strategy. An 
understanding of prevailing social, cultural and moral beliefs 
and attitudes is also important for ensuring that the chosen 
policies reflect the views of, and are acceptable to, the 
majority of citizens. Pike noted the last nationwide general 
population survey of knowledge, attitudes and beliefs 
regarding illicit drugs and drug use in Ireland was conducted 
over a decade ago.4 
(Brigid Pike)
1. Latin American Commission on Drugs and Democracy 
(2009) Drugs & democracy: toward a paradigm shift. Accessed 
28 September 2012 at www.drogasedemocracia.org ; Global 
Commission on Drug Policy (2011) War on drugs: Report of 
the global commission on drug policy. Accessed 28 September 
2012 at www.globalcommissionondrugs.org ; House of 
Lords European Union Committee (2012) The EU drugs 
strategy report. 26th report of session 2010–2012. HL Paper 
270. Accessed 28 September 2012 at www.parliament.uk/
business/committees/committees-archive/lords-s-comm-f/
eufwrevid/ ; Home Affairs Committee (2012). Drugs: Breaking 
the Cycle. 9th Report of Session 2012–2013. HC 184–I 
[incorporating HC 1774 of Session 2010–12. Accessed on 
14 May 2013 at www.parliament.uk/business/committees/
committees-a-z/commons-select/home-affairs-committee/
publications/previous-sessions/session-2012-13 
2. Alexander J (2008) The civil sphere. Oxford: Oxford University 
Press.
3. See Pike B (2012) Politicians and the drug debate – 6 years 
on. Drugnet Ireland, (41): 7–8. www.drugsandalcohol.
ie/17272/ 
4. Bryan A, Moran R, Farrell E and O’Brien M (2000) Drug-
related knowledge, attitudes and beliefs in Ireland: report of a 
nation-wide survey. Dublin: Health Research Board.  
www.drugsandalcohol.ie/5202/
Incarceration as a health strategy – 
imprisonment for drug offences  
in Ireland
Reviewing Ireland’s history of using prison sentences, 
particularly medium- to long-term sentences, as its ‘main 
tactic’ in tackling the illicit drug market, and analysing 
trends in the prison population over the same period, 
Liam Herrick (IPRT), the second presenter at the CityWide 
conference, argued that the tactic had not been effective. 
He also showed that the policy approach is not based on any 
strong evidence.
In outlining the history of prohibition in Ireland, Herrick 
singled out two key ‘moments’ – (1) the Misuse of Drugs Act 
(MDA) 1977 which introduced a 14-year maximum sentence 
for distribution of illegal drugs, followed by the MDA 1984, 
which increased the maximum possible sentence to life, and 
(2) the Criminal Justice Act 1999 which inserted Section 15A 
in the MDA 1977, creating a mandatory minimum sentence 
of 10 years for the illegal distribution of controlled drugs 
over the value of €13,000. Herrick noted that in the 1980s 
and 1990s long sentences were consistently imposed on 
senior figures in the illegal drugs trade in Ireland. He went 
on to describe how this changed after the introduction of 
Section 15A in 1999, with long sentences being applied to 
minor figures in the drug trade on a large scale.
Looking at the size and profile of the Irish prison population 
from the 1960s onwards, Herrick noted that it had increased 
from less than 500 in 1960 to nearly 4,500 today, and that 
there was a particularly rapid increase in the first decade of 
the new century. He argued that this increase was partly due 
to the introduction of mandatory drug sentencing in 1999. 
He pointed to two statistics supporting this assertion:
 ■ Between 2005 and 2009, the number of charges brought 
by the gardaí in most categories, e.g. theft and burglary, 
remained static but drug supply offences doubled.
 ■ Over the same period, the number of short-term 
sentences and life sentences remained stable but the 
number of 3–10-year sentences increased substantially. 
He linked this to an increase in the number of circuit 
court and high court prosecutions of drug offenders 
receiving 3–10 year sentences. Moreover, almost 
uniquely in the Irish sentencing regime, people convicted 
for medium-term sentences under the MDA, including 
Section 15A, are not eligible for temporary release or 
community return. 
Almost uniquely in the Irish sentencing regime, people 
convicted under the MDA, including Section 15A, are not 
eligible for temporary release or community return. Herrick 
suggested this is another reason for the bulge in the number 
of prisoners serving medium-term sentences. 
Who are these people getting Section 15A sentences of  
3–10 years? Herrick described a sample study that IPRT did, 
using the Irish Sentencing Information System, to see how 
many of these prisoners were senior drug figures. The study 
found that:
 ■ more than one third had no previous conviction,
 ■ more than three-quarters had not been in prison before,
CityWide>conference>presentations>(continued)
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 ■ more than one quarter had mental health problems, 
 ■ almost half suffered from alcohol addiction, and
 ■ fewer than one in eight could be reasonably identified as 
being a senior figure in the drugs trade.
Given the profile of these offenders, Herrick pointed out that 
they are at a much lower risk of reoffending and should be 
eligible for temporary release or community return. 
Herrick cited research from Australia,1 the USA2 and Ireland,3 
which found that presumptive drug offence sentencing 
regimes were not effective in reducing levels of  
criminality. He noted that the UK, which also operates a 
presumptive sentencing regime, has recently moved to a 
more nuanced approach, requiring the type of drug involved 
and the person’s role in the drug trade to be taken  
into consideration.4 
Herrick concluded by proposing some ‘modest ideas for 
reform within the criminalisation context’:
 ■ repeal Section 15A of the MDA 1977 completely, 
 ■ adjust the monetary amount upwards, 
 ■ amend the presumptive sentencing regime to refocus on 
the role played by the offender in the drugs trade and/or 
the substance involved, or
 ■ allow for the structured temporary release of all prisoners 
serving presumptive sentences (including access to 
community return). 
Even adopting the last three ideas would, Herrick suggested, 
have an immediate effect on the size of the Irish prison 
population and the problem of overcrowding. He observed 
that some 400 prisoners, 10% of the total prison population, 
who are currently serving 3–10-year sentences for drug 
dealing, are not senior figures in the drug trade and could be 
eligible for temporary release.
(Brigid Pike)
1. Law Institute of Victoria (2011) Mandatory minimum 
sentencing. Melbourne: Law Institute of Victoria. Available at 
www.liv.asn.au/getattachment/22c3c2c9-45a5-45c4-96e6-
f0affdfe2ff8/Mandatory-Minimum-Sentencing.aspx
2. Caulkins JP, Rydell CP, Schwabe WL and Chiesa J (1997) 
Mandatory minimum sentences: throwing away the key or 
the taxpayers’ money? MR-827-DPRC. Santa Monica, CA: 
Rand. Available at www.rand.org/pubs/monograph_reports/
MR827.html 
3. Law Reform Commission (2013) Report: mandatory sentences. 
LRC 108–2013. Dublin: LRC. Available at  
www.drugsandalcohol.ie/20242
4. Sentencing Council (2012) Drug offences: definitive guideline. 
London: The Sentencing Council for England and Wales. 
Available at http://sentencingcouncil.judiciary.gov.uk/docs/
Drug_Offences_Definitive_Guideline_(web).pdf 
Beyond criminalisation
The dominant paradigm for understanding the effects 
of drug laws is the rational choice perspective derived 
primarily from classical economic theory. This theory rests 
on the assumption that people are rational actors capable 
of evaluating the consequences of alternative choices. It 
also assumes that human behaviour is essentially hedonistic 
and motivated by the desire for pleasure and the avoidance 
of pain. The purpose of the criminal law is to make the 
punishment for criminal behaviour greater than the pleasure 
to be derived from it. 
The distinctive features of deterrence were described by 
McLaughlin (2006)1:
Deterrence requires three key elements:
 ■ The certainty of apprehension, conviction  
and punishment.
 ■ The severity of the punishment to be greater than the 
potential benefits of the criminal act.
 ■ The clarity of punishment to ensure that the offender 
is in a position to make the link between her/his 
punishment and her/his criminal behaviour. (p.125)
When applied in the context of the decision to use 
illicit drugs, the rational choice perspective emphasises 
three factors that impact on decision-making: the drug’s 
availability, the price of the drug and the risk of apprehension 
and punishment. Drug laws aim to restrict supply and 
availability, thereby increasing the price and discouraging 
use. Although drug policy and drug law enforcement 
rests heavily on deterrence theory, little research has been 
conducted in Ireland on its effectiveness in deterring drug 
use and drug dealing.
In the Irish context, O’Mahony (2008)2 situates the Misuse 
of Drugs Act 1977 ‘at the heart of the prohibitionist system 
and the manner and effectiveness of its enforcement to a 
significant extent defines the reality of the Irish “war on 
drugs”’ (p.68). The Act was introduced in the context of a 
relatively non-problematic drug scene in the mid-1970s, but 
one that would soon escalate. In the mid-1990s with the 
resurgence of the heroin crisis and, in particular, following 
the assassination of Veronica Guerin by people involved in 
the drug trade, a series of further quite draconian legislative 
measures were adopted, including the establishment of 
the Criminal Assets Bureau, enhanced Garda detention 
powers, restrictions to the bail laws, provisions to respond 
to organised crime and mandatory sentencing provisions in 
drug cases. This process of legislating in response to crisis has 
been described by many legal commentators as a form of 
legislation by ‘moral panic’.3
When considering the impact of criminalisation it is 
important to move beyond the often heated rhetoric that 
can accompany debates about drug laws and the so-called 
‘war on drugs’, and analyse how precisely the laws we have 
are actually implemented on a day-to-day basis by the  
Garda Síochána. 
Figure 1 shows trends in prosecutions for the main drug 
offences of supply and possession between 1993 and 2005. 
It is clear from these data that the vast majority of drug 
offences prosecuted are for the simple possession of drugs 
for personal consumption, with seizure data showing that 
this is mostly cannabis-related.4 The large spike in such 
prosecutions between 1996 and 1998, it is suggested, was 
a consequence of the Veronica Guerin murder. Despite the 
intense political reaction to this event, it is apparent that 
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actual drug law enforcement involved merely a sharp but 
temporary increase in simple cannabis possession  
charges, primarily as a consequence of routine Garda  
‘stop and search’ activity, while supply offences increased 
only marginally.5
Furthermore, it is important to consider against whom 
such ‘stop and search’ powers are generally employed. 
The reality of day-to-day police work is that it involves a 
significant degree of discretion in terms of how and against 
whom police powers are typically directed. Research in other 
jurisdictions has shown how police ‘stop and search’ powers 
are often used disproportionately against ethnic minority 
and socially marginalised groups.6 Irish research in this area 
is limited. However, although a large number of middle-
class people in Irish society regularly consume drugs, often 
on a recreational basis, the profile of the ‘drug criminal’, as 
reflected for example in those who end up imprisoned for 
drug-related crime, has remained consistent over time. They 
are typically young working-class males who left school early 
and are from areas with high levels of unemployment or they 
are ‘drug mules’ who perform relatively minor roles in the 
overall drug trade.7
The evidence suggests that drug availability and use 
and drug-related criminality appear to have been largely 
unaffected by the many new legal measures referred to 
above as illicit drug markets have penetrated more deeply 
into the fabric of many communities; these markets have 
become more diverse in terms of the drugs available, 
populated by ever-younger people and more violent. 
Meanwhile, drug prices have declined throughout Europe 
in recent decades. This is not to suggest that drug law 
enforcement has no value. As Roberts et al. (2005: 2) point 
out, ‘failure to reduce prevalence does not mean that supply 
reduction initiatives (and, specifically, law enforcement) 
are having no impact on drug markets. It is widely – and 
reasonably – argued that supply reduction contains the 
expansion of drug markets, even if it fails to reduce markets.’8
However, the failure of prohibition/criminalisation to 
significantly reduce drug use and availability, the resilience 
and adaptability of illicit drug markets in the face of highly-
resourced drug law enforcement, coupled with the often 
negative consequences of prohibition, has led to calls for 
a fundamental re-examination of the international system 
of drug prohibition. These calls have come from countries 
at all levels of the international drug trade – production, 
transit and consumption. Policy options advocated include 
changes to the legal status of drugs, whether through 
direct legalisation or some form of decriminalisation, and 
a realignment of the balance between criminal justice and 
harm reduction approaches.
The recent ‘head shop’ phenomenon in Ireland should 
send a note of caution to advocates of drug legalisation in 
this country. The evidence from this experience suggests 
that legalisation in a free market economy would lead to 
an increase in experimentation and use by young people 
as a consequence of increased availability and aggressive 
marketing.9 A liberalisation of drug laws would also be 
counter to recent moves towards greater regulation in 
relation to tobacco and, increasingly, to the other principal 
mind-altering substance in Irish society, alcohol. Another 
question that advocates of legalisation need to address 
is: How will legalisation improve the situation in those 
communities where the sale and use of drugs have had the 
most pernicious effects?
On the other hand, there is evidence about the beneficial 
impact of decriminalisation, at least as it has been introduced 
in Portugal.10 The Portuguese experiment, which involves 
decriminalisation within the context of an overall harm-
reduction approach, has led to a number of positive 
outcomes, including a large reduction in drug-related 
deaths. Although it initially led to a slight increase in drug 
use among some groups, this was not sustained over 
time. It now has broad political support, even from former 
opponents of the strategy.
(Johnny Connolly)
1. McLaughlin E (2006) Deterrence. In McLaughlin E and 
Muncie J (eds) The SAGE dictionary of criminology. 2nd 
edition. London: SAGE.
2. O’Mahony P (2008) The Irish war on drugs: the seductive folly 
of prohibition. Manchester: Manchester University Press.
3. Cohen S (1980) Folk devils and moral panics: the creation 
of mods and rockers. Oxford: Martin Robinson. For an Irish 
application of ‘moral panic’ theory see: Hamilton C (2005) 
Moral panic revisited: part 1. Irish Criminal Law Journal, 
15(1): 8–12. 
4. For further discussion of these data see: Connolly J (2005) 
The illicit drug market in Ireland. HRB Overview Series 2. 
Dublin: Health Research Board and Connolly J (2006) Drugs 
and crime in Ireland. HRB Overview Series 3. Dublin: Health 
Research Board.
5. It should be noted that the intelligence-led nature of 
supply level enforcement means that far more resources are 
involved in this police activity.
6. For a discussion see Reiner R (1997) Policing and the police. 
In Maguire M, Morgan R and Reiner R (eds) The Oxford 
handbook of criminology. 2nd edition. Oxford: Oxford 
University Press.
7. See article on mandatory sentencing on p. 32 of this issue.
8. Roberts M, Trace M and Klein A (2005) Law enforcement 
and supply reduction. Drugscope report for the Beckley 
Foundation Drug Policy Programme. Report 3. Oxford: 
Beckley Foundation. http://reformdrugpolicy.com/library/
9. Kelleher C, Christie R, Lalor K et al. (2011) An overview of 
new psychoactive substances and the outlets supplying them. 
Dublin: National Advisory Committee on Drugs.
10. Connolly J (2009) Report examines effects of 
decriminalisation of drugs in Portugal. Drugnet Ireland, (30): 
22–23.
drugnet>
Ireland
Figure 1 Trends in supply, possession and total drug 
offence prosecutions 1993–2005
Source: Annual reports of An Garda Síochána 1993–2005
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Global trends in decriminalisation 
Decriminalising drug possession does not lead to any 
statistical increase in drug use. This was the key message 
of the final presenter at the CityWide conference, Niamh 
Eastwood, executive director of UK-based Release.1  
She spoke about a recent Release report on drug 
decriminalisation policies around the world.2
Decriminalisation means the removal of criminal sanctions 
for illegal drug possession. Release sees decriminalisation as 
being especially important because it means that individuals 
do not end up with a criminal record. Release argues that it 
is the criminal justice approach to drugs that has led to the 
greatest harms to individuals and to society: it has spawned 
generations of people isolated from mainstream society 
as a result of incarceration, issue avoidance, or the stigma 
attached to drug use.
Speaking to a map of the world, Eastwood highlighted the 
various approaches to decriminalisation in the 21 countries 
described in the report. She defined two main approaches to 
decriminalising drug use:
 ■ de jure, based on legislation that removes the criminal 
sanctions for possession, or based on a constitutional 
ruling that criminalising drug possession is contrary to 
the country’s constitution, or 
 ■ de facto, where drug possession is a criminal offence on 
the statute book but the police and the prosecution do 
not enforce the law. 
Eastwood gave examples of where decriminalisation of drug 
possession had had a positive impact on drug use prevalence 
and problematic drug use. However, she identified 
implementation issues to be aware of:
 ■ Fine-tuning the mechanism: Any decriminalisation policy 
needs careful monitoring and adjustment. For example, 
in South Australia, ‘net widening’ was found to occur: 
because the fine for drug possession had been set too 
high and a payment plan had not been put in place, 
many people ended up in prison for non-payment of 
the fine. The authorities adjusted the system, reducing 
the level of the fines and allowing for payment in 
instalments. 
 ■ Politicians may be part of the problem: Owing to a 
combination of hypocrisy, by being tough on drug users 
while also admitting to having used drugs in the past, 
and stupidity, through failing to listen to the debate 
or admit the need for review, politicians may delay the 
process of devising more effective drug policies.
 ■ Incrementalism: Decriminalisation is not a panacea; it 
does not have any significant impact on the supply side 
or on drug-related crime. But Eastwood argued that it 
is part of an incremental reform process, as evidenced 
by subsequent reforms such as the establishment 
of cannabis social clubs in Spain, the legalisation of 
medicinal cannabis in the Czech Republic, and the 
setting up of fully regulated cannabis markets in the 
states of Washington and Colorado, and in Uruguay. 
Release’s survey of countries which have decriminalised drug 
use is the first of three reports in support of its campaign 
‘Drugs – It’s Time for Better Laws’, which was launched in the 
UK in June 2011. The second report, due in 2013, will look 
at the disproportionate impact of policing and prosecution 
of drug possession offences on black and Asian communities 
in the UK. The final report, due in 2014, will look at the 
economic costs associated with policing and prosecuting the 
possession of drugs in the UK. 
(Brigid Pike)
1. For more information on Release, visit www.release.org.uk
2. Rosmarin A and Eastwood N (2012) A quiet revolution: drug 
decriminalisation policies in practice across the globe. London: 
Release. Available to download at http://release.org.uk/
publications/drug-decriminalisation-policies-in-practice-
across-the-globe 
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2013 UN world drug report 
The UN’s annual report on the world drug situation1 shows 
that while the use of traditional drugs such as heroin and 
cocaine seems to be declining in some parts of the world, 
prescription drug abuse and new psychoactive substance 
abuse is growing. 
New psychoactive substances have proliferated at an 
unprecedented rate, rising from 166 at the end of 2009 
to 251 by mid-2012, an increase of more than 50%. This 
number exceeds the total number of substances (234)  
under international control. 
While noting that different countries have adopted different 
responses to the spread of new psychoactive substances, 
for example early warning systems, emergency scheduling, 
generic scheduling (the option used in Ireland), or 
application of the medicines law, and that each has its pros 
and cons, the UN report argues that co-ordination at the 
global level is essential. Global co-ordination is the only 
means to ensure drug dealers do not exploit loopholes: 
‘What is needed is an understanding and sharing of methods 
and lessons learned in regional responses to the situation 
involving new psychoactive substances before exploring the 
setting up of a global response to the problem’ (p.xiv).
The global picture for the use of traditional drugs such as 
heroin and cocaine shows some stability. In Europe, heroin 
use seems to be declining, while, the cocaine market seems 
to be expanding in South America and in the emerging 
economies in Asia. Use of opiates (heroin and opium), on the 
other hand, remains stable, although a high prevalence of 
opiate use has been reported from South-West and Central 
Asia, Eastern and South-Eastern Europe and North America. 
In terms of production, Afghanistan retained its position as 
the lead producer and cultivator of opium globally (75% of 
global illicit opium production in 2012). But given a poor 
yield in 2012, owing to a plant disease affecting the opium 
poppy in Afghanistan, global opium production fell to 3% 
less than in 2011 and 40% less than in the peak year of 
2007. The world's largest cocaine seizures, unadjusted for 
purity, continue to be reported from Colombia and the US. 
Cocaine use continues to fall in the US, the world's largest 
cocaine market. In contrast, significant increases in seizures 
have been noted in Asia, Oceania and Central and South 
America, and the Caribbean in 2011. Africa is emerging 
as a target for the trafficking as well as production of 
illicit substances.
The use of amphetamine-type stimulants (ATS), excluding 
ecstasy, remains widespread globally and appears to be 
increasing in most regions. The prevalence of ecstasy in 
2011 was lower than in 2009. Methamphetamine continues 
to dominate the ATS business, accounting for 71% of global 
ATS seizures in 2011. Methamphetamine pills remain the 
predominant ATS in East and South-East Asia. Seizures 
of crystal methamphetamine in the region increased 
to 8.8 tons, the highest level during the past five years, 
indicating that the substance is an imminent threat. Mexico 
recorded its largest seizures of methamphetamine, more 
than doubling within a year from 13 tons to 31 tons, thus 
representing the largest reported seizures globally. 
Cannabis remains the most widely used illicit substance. 
While cannabis use has clearly declined among young 
people in Europe over the past decade, there was a minor 
increase in the prevalence of cannabis users, as compared 
with previous estimates in 2009.
There continues to be a major shortfall in the delivery of 
treatment services for drug dependence: only an estimated 
one in six problem drug users had received treatment in 
the preceding year. However, the report shows that there 
have been some improvements. Those countries which 
implemented a comprehensive set of HIV interventions were 
able to achieve a reduction in high-risk behaviours and in the 
transmission of HIV and other blood-borne infections. 
Compiled by the UN Office for Drugs and Crime (UNODC), 
the report is released each year on International Day against 
Drug Abuse and Illicit Trafficking, 26 June. In his preface to 
the report, UNODC executive director, Yury Fedotov, writes: 
‘We have to admit that, globally, the demand for drugs has 
not been substantially reduced and that some challenges 
exist in the implementation of the drug control system, in 
the violence generated by trafficking in illicit drugs, in the 
fast evolving nature of new psychoactive substances, and 
in those national legislative measures which may result in a 
violation of human rights.’
Fedotov argues, however, that the solution is not to amend 
the Conventions, but to implement them according to 
their underlying spirit. The problem will not be resolved 
if drugs are legalised: organised crime is highly adaptive, 
and will simply move to other businesses that are equally 
profitable and violent. The underlying spirit of the 
Conventions, according to UNODC’s executive director, 
is health: ‘Advocacy for a stronger health perspective and 
an interconnected re-balancing of drug control efforts 
must take place. As experience has shown, neither supply 
reduction nor demand reduction on their own are able 
to solve the problem. For this reason, a more balanced 
approach in dealing with the drug problem is a necessity. 
This includes more serious efforts on prevention and 
treatment, not only in terms of political statements, but  
also in terms of funds dedicated for these purposes.’ 
(Brigid Pike)
1. United Nations Office on Drugs and Crime (2013) World 
drug report 2013. Vienna: UNODC. www.drugsandalcohol.
ie/20073/ 
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Towards UNGASS 2016
UNGASS 2016 is a Special Session of the General Assembly of 
the United Nations, scheduled for early 2016, at which member 
states, including Ireland, will assess ‘the achievements and 
challenges in countering the world drug problem, within the 
framework of the three international drug control conventions’ 
(A/RES/67/193). The last UNGASS on drugs, in 1998, adopted 
a plan to make the world ‘drug-free’ by 2008. This column 
reports on policy initiatives, research, reviews, conferences 
and debates launched by member states and civil society 
organisations that are relevant to UNGASS 2016.1 
In May 2013 the Canadian Drug Policy Coalition, 
comprising 30 Canadian NGOs who came together in 
2009 to advocate for improvements in Canada’s approach 
to drug policy, published Getting to tomorrow: a report on 
Canadian drug policy. The authors call for ‘a radical new 
direction – a course that will put the protection of public 
health and safety, social justice and equity at the forefront 
of Canada’s strategy’. They identify four broad areas where 
improvements should be made: (1) modernise Canada’s 
legislative, policy and regulatory frameworks that address 
psychoactive substances, replacing the national anti-drug 
strategy with one focused on health and human rights, 
the decriminalisation of all drugs for personal use and the 
creation of a regulatory system for adult cannabis use;  
(2) support and expand efforts to implement evidence-based 
approaches to eliminate stigma and discrimination, and 
social and health inequities that affect people who use drugs; 
(3) support the scaling-up of health and social services at the 
provincial level that engage people with drug problems and 
support their efforts to change, and support work to reduce 
the harms of substance use; and (4) improve the collection 
of data on substance use and its effects across jurisdictions. 
www.drugpolicy.ca/progress/getting-to-tomorrow/ 
In May 2013 the Organisation of American States (OAS), 
comprising 35 states in North and South America, published 
a 400-page report on the drug problem in the Americas. 
The objective was to collect ‘empirical evidence without 
prejudice’ and to explore possible future scenarios while not 
‘defending any position, neither legalisation, nor regulation, 
nor war at any cost’. The report is in two main parts. The 
drug problem in the Americas examines the entire process 
of drugs in the region, the only part of the world in which 
all of its stages are present in a dominant way: cultivation, 
production, distribution and the final sale of controlled 
substances. Scenarios for the drug problem in the Americas 
2013–2025 explores the paths that the drug phenomenon 
could take in the hemisphere in the coming years. Three of 
the four scenarios describe different future alternatives:  
(1) Together, shifting from repressive approaches to ones 
that privilege citizen security and focusing on institution-
building; (2) Pathways, experimenting with different 
approaches to regulating illicit drugs, and (3) Resilience, 
strengthening communities’ capacity to respond to the 
problem. The fourth scenario, Disruption, outlines what 
could happen if states are incapable in the short run of 
reaching a shared vision that allows them to join forces to 
address the problem. 
The report presents four broad conclusions: 
1. options for dealing with the drug problem must take 
into account each country’s particular situation; 
2. countries with fewer resources and less institutional 
strength have more difficulty dealing with the impact  
of drug trafficking; 
3. the drug phenomenon requires a public health 
approach; and 
4. the approach to the problem must be multifaceted, 
flexible, and allow countries to collectively explore  
policy options on drugs, taking into consideration the 
needs, behaviours and particular traditions of each. 
www.cicad.oas.org/Main/Template.asp?File=/main/
policy/default_eng.asp 
In June 2013 the Global Commission on Drug Policy 
published The negative impact of the war on drugs on public 
health: the hidden hepatitis C epidemic. The report finds 
that of the 16 million people who inject drugs around the 
world, an estimated 10 million are living with hepatitis 
C. The report recommends immediate, major reforms of 
the global drug prohibition regime to halt the spread of 
hepatitis C infection and other drug war harms. www.
globalcommissionondrugs.org/hepatitis/ 
In July 2013 the Open Society Global Drug Policy 
Program, launched in 2008 and funded by George Soros’ 
Open Society Foundations, published Coffee shops and 
compromise: separated illicit drug markets in the Netherlands. 
A central element of modern Dutch drug policy has been 
the legal and practical separation of cannabis – judged to 
pose ‘acceptable’ risks to consumers and society – from hard 
drugs associated with unacceptable risk. The report describes 
the policy’s positive impact on patterns of drug use and in 
reducing drug-related harms. It also examines the policy’s 
negative effects, including public nuisance complaints 
and tensions arising from the supply of what is still an 
illegal substance. The report shows how, with its regulated 
approach to ‘coffee shops’, the Netherlands has been able 
to use regulatory mechanisms to address these problems. 
The authors conclude that, if there is one lesson to take 
away from the Dutch experience, it is that when taking 
steps toward regulating cannabis or other psychoactive 
substances, these should include the whole supply chain, 
from production to consumption.  
www.opensocietyfoundations.org/reports/coffee-shops-and-
compromise-separated-illicit-drug- 
markets-netherlands 
 (Compiled by Brigid Pike)
1. While every effort will be made to describe in this column 
a broad range of initiatives, from a variety jurisdictions and 
civil society organisations, it will not be possible to provide 
comprehensive coverage.
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EU action plan on drugs  
2013–2016 adopted
On 6–7 June 2013 the European Council adopted the new 
EU action plan on drugs for 2013–2016.1 Linked to the EU 
drugs strategy for 2013–2020,2 this action plan is organised 
around five pillars:
 ■ Drug demand reduction
 ■ Supply reduction
 ■ Co-ordination
 ■ International co-operation
 ■ Information, research, monitoring and evaluation 
As the principle of ‘subsidiarity’ applies to illicit drug policy, 
i.e. member states have responsibility for drug policy within 
their borders, the action plan uses three policy instruments 
depending on whether there are opportunities for joint 
actions or cross-border co-operation. 
1.  Frameworks for co-ordinated and joint actions
Member states can either work together or co-ordinate their 
efforts under three pillars – Supply Reduction; Information, 
Research, Monitoring and Evaluation; and Co-ordination.
The Supply Reduction pillar includes a range of actions 
designed to enhance law enforcement and judicial co-
operation between different member states, based on 
enhanced intelligence, threat assessments and information-
sharing, and on use of mechanisms such as joint operations, 
joint investigation teams, memorandums of understanding 
and European arrest warrants. New emphases in the action 
plan include:
 ■ a stronger focus on tackling money laundering, asset 
confiscation and drug trafficking;
 ■ strengthening the law relating to new psychoactive 
substances and drug precursors;
 ■ adopting and implementing EU regulations relating to 
the use of cutting agents; 
 ■ developing strategic responses to the emergence of 
drug-related crime via the internet, and training law 
enforcement personnel to combat the use of new 
communication technologies in illicit drug production 
and trafficking; and
 ■ providing, where appropriate in accordance with 
member states’ legal frameworks, alternatives to coercive 
sanctions for drug using offenders.
The Information, Research, Monitoring and Evaluation pillar 
lists three objectives, which mirror the main functions of the 
European Centre for Drugs and Drug Addiction (EMCDDA), 
which funds a network of Reitox National Focal Points across 
all 28 member states:
 ■ research and data collection, including funding research, 
and ensuring the accuracy, relevance and timeliness of 
monitoring, reporting and evaluation activities by all 
member states;
 ■ maintaining networking and co-operation, and building 
capacity, with special emphases on improving capacity 
to detect, assess and respond to new psychoactive 
substances, strengthening efforts to share forensic 
science data across member states, and improving the 
ability to identify, assess and respond to behavioural 
changes in drug use and epidemic outbreaks; and 
 ■ dissemination of monitoring, research and evaluation 
results, ensuring all member states co-operate and 
support the EMCDDA’s work.
Responsibility for co-ordinating and monitoring the 
implementation of the EU drugs strategy and action plans 
lies with the holders of the EU presidency and the Horizontal 
Working Party on Drugs (HDG), a working party of the 
European Council. Implicit in this arrangement is a stronger 
role for member states that rotate the EU presidency and 
have diplomatic representation on the HDG.
The HDG takes on responsibility for promoting and 
supporting dialogue with both civil society and the scientific 
community (natural and social science and behavioural 
research) regarding the development and implementation 
of drug policy. The EU Civil Society Forum on Drugs will 
continue to represent civil society at EU level, but the 
European Alliance on Drugs, formed by the European 
Commission under the last EU drugs action plan, is not 
mentioned in the new action plan.3
2.  Political framework for EU external co-operation in 
drugs field
The International Co-operation pillar proceeds on three 
diplomatic fronts, requiring policy positions to be based  
on the priorities and balanced approach set out in the EU 
drugs strategy:
 ■ external relations, including initiatives to support 
alternative development, implement risk and harm 
reduction initiatives, tackle drug-related organised  
crime, including drug trafficking, maintain dialogues  
and declarations with external partners, ensuring  
the promotion and protection of human rights in  
the dialogues; 
 ■ UN and other international bodies, including improving 
the cohesiveness of the EU’s approach and its visibility in 
UN forums, and strengthening partnerships with UN and 
other international bodies; and
 ■ acceding countries, candidate countries and potential 
members of the EU, supporting their adaptation to and 
alignment with the EU acquis in the drugs field.
3.  Strategic approach that supports and complements 
national policies
Regarding demand reduction, the action plan calls on 
member states to measure, in association with the EMCDDA, 
the implementation of actions in three broad areas – 
prevention; treatment and rehabilitation; and co-ordinated, 
best-practice and quality approaches to drug demand 
reduction. New initiatives include tackling the misuse of 
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Status report on alcohol and health  
in Europe
In 2012, the WHO Regional Office for Europe collected 
information on alcohol consumption and related harm, 
and countries’ policy responses to contribute to the Global 
Information System for Alcohol and Health. The resultant report 
presents a selection of the results for 35 countries – EU member 
states and candidate countries, and Norway and Switzerland.1 
Alcohol consumption and related harm
The most recent data collected from the 35 countries show that 
adults aged 15 years and over consumed 9.4 litres of alcohol 
per capita in 2010. The corresponding figure for EU countries 
only was 10.2 litres. There was a marked decrease in recorded 
adult per capita alcohol consumption in the EU as a whole 
between 1990 and 2010. This was mainly due to a reduction in 
consumption in southern European countries (Cyprus, Greece, 
Italy, Malta, Portugal, and Spain) that started before 1990.
Alcohol has been established as a major risk factor for premature 
mortality in the EU, and the overall level of alcohol-attributable 
mortality in the EU is high, as measured by mortality due to 
the three most important alcohol-attributable causes of death, 
namely, cancers, liver cirrhosis and injuries. Alcohol-attributable 
mortality was highest in the central-eastern and eastern country 
group (Bulgaria, Croatia, Czech Republic, Estonia, Hungary, 
Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia), 
where alcohol consumption is on the increase. According to the 
report: ‘A simple regression analysis indicates that the correlation 
between adult per capita consumption of alcohol and alcohol-
attributable mortality is strong (R2 = 0.70), and that the number 
of alcohol-attributable deaths increases exponentially as adult per 
capita consumption increases’ (p.7).
Alcohol consumption can result in many types of harm to people other than the drinker, which are difficult to quantify. This 
report estimates only the alcohol-attributable harm to others due to motor vehicle accidents and assaults. In the EU, Croatia 
and Switzerland in 2010, 1.04 deaths per 100,000 people (0.56 deaths per 100,000 women and 1.55 deaths per 100,000 
men) were caused by alcohol-attributable motor vehicle accidents and assaults. This represents 9.9% of all alcohol-attributable 
injury deaths (30.2% of all alcohol-attributable injuries for women and 7.9% of all alcohol-attributable injuries for men). The 
burden of alcohol-attributable harm to others was greatest in the central-eastern and eastern country group, with 2.23 deaths 
per 100,000 people (1.20 deaths per 100,000 women and 3.36 deaths per 100,000 men).
European survey on alcohol and health 2012
Part 2 of the report presents the results of the EC/WHO survey on alcohol and health, carried out in 2012. The survey was sent 
to the national WHO focal points for alcohol policy in each country, to be completed in consultation with various national 
experts. Respondents were asked to rate whether action in various policy areas had been strengthened, weakened or remained 
prescribed and ‘over-the-counter’ opioids, and providing 
recovery and social re/integration services alongside 
treatment and rehabilitation.
Measuring performance
The action plan includes a list of 15 overarching indicators 
that will be used to assess the overall effectiveness of the 
action plan. Fourteen of these indicators are based on data 
already collected by the EMCDDA. The use of additional 
indicators will depend on member states providing extra 
data on topics such as the level and patterns of prescribing 
of psychoactive medicines, or the level of involvement of civil 
society in drug policy development and implementation, 
with particular regard to the involvement of drug users, 
clients of drug-related services and young people. The action 
plan emphasises the need to increase the availability and 
use of evidence-based and scientifically sound indicators. 
Work is to continue on developing a roadmap to standardise, 
improve and streamline data collection of key drug supply 
indicators and getting agreement from all member states on 
these indicators. 
(Brigid Pike)
1. Council of the European Union (2013) Draft EU action plan 
on drugs (2013–2016). 9963/13. Brussels: Council of the 
European Union. www.drugsandalcohol.ie/20004 
2. See Pike B (2013) New EU drugs strategy reflects ‘new 
thinking’. Drugnet Ireland, (45): 7. www.drugsandalcohol.
ie/19683 
3. See Pike B (2009) EU sets priorities for drug policy 2009–
2012. Drugnet Ireland, (29): 25–26. www.drugsandalcohol.
ie/12180
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Alcohol>and>health>in>Europe>(continued)
unchanged over the past five years. 
The areas in which the most countries (excluding the five 
EU candidate countries) reported positive developments 
were public awareness-raising (23 countries), drink-driving 
policies and countermeasures (22 countries), and monitoring 
and alcohol research (21 countries). Two thirds of the 
countries (20) reported strengthened action in controlling 
the availability of alcohol. However, two of the most 
effective policy measures have seen fewer positive policy 
developments in recent years, with the majority of countries 
reporting that policies to control the affordability of alcohol 
(17 countries) and policies to regulate the marketing of 
alcoholic beverages (19 countries) had either been weakened 
or remained unchanged. At the end of 2011, 23 countries 
had a written national policy on alcohol; six of the remaining 
seven were in the process of developing such a policy.
According to the report:
All 30 countries reported that excise duty is levied on 
beer and spirits. However, just over one third of the 
countries do not have an excise duty on wine. Only 
four countries reported that the level of excise duty 
is regularly adjusted for inflation. … A few countries 
reported using price measures other than taxation. At the 
end of 2011, Germany and Sweden prohibited below-
cost selling (selling for a price less than the production 
cost), and Finland and Sweden prohibited volume 
discounts (such as two-for-one offers) (p.20). 
Major steps or milestones in the development of policy 
Alcohol policy timelines for each country were also reported. 
These timelines are a summary of the major steps taken  
or milestones reached in each country in the development  
of policy and action to reduce alcohol-related harm during 
the period 2006–2012. The milestones reported by  
Ireland include:
 ■ the establishment of the Government Alcohol Advisory 
Group in 2007 to examine the law governing the sale 
and consumption of alcohol;
 ■ The Intoxicating Liquor Act 2008;
 ■ the establishment of a code of practice on the display 
and sale of alcohol in mixed trading premises in 2008;
 ■ the enactment of the Road Traffic Acts 2010 and 2011, 
which reduced the maximum legal blood alcohol 
concentration (BAC) when driving a vehicle, and made 
provision for the mandatory testing of drivers at collision 
sites and in hospital following a road traffic collision; and
 ■ the publication of Steering group report on a national 
substance misuse strategy in 2012, which is a roadmap 
for the future direction of policy to deal with the use and 
misuse of alcohol.
Conclusion
The report concludes:
In principle, all alcohol-attributable deaths are avoidable, 
and there are clear indications that policy measures 
can be implemented which could decrease alcohol-
attributable mortality markedly in a relatively short period 
of time. The most important of these measures would 
be increased taxation, decreased availability, bans on 
advertising and marketing, and an increase in treatment 
rates for people with alcohol problems. (p.11)
 (Deirdre Mongan)
1. World Health Organization (2013) Status report on alcohol 
and health in 35 European countries 2013. Copenhagen: 
WHO Regional Office for Europe. www.drugsandalcohol.
ie/20017
Physicians urge action on alcohol-
related harm
The Royal College of Physicians (RCPI) established a policy 
group on alcohol in 2012. Its members are all experienced 
medical professionals working in a variety of disciplines and 
its remit is to highlight the rising levels of alcohol-related 
health harm in Ireland, to propose evidence-based solutions 
to reducing this harm, and to influence decision-makers to 
take positive action to address the damage caused by  
alcohol use. The group published its first policy statement  
in April 2013.1
The policy statement outlines the evidence regarding alcohol 
consumption and alcohol-related harm in Ireland: 
 ■ Ireland’s adult per capita consumption of alcohol was 
11.9 litres in 2010, the sixth highest level of consumption 
in the European Union that year.
 ■ In 2008, there were 88 deaths every month which were 
directly attributable to alcohol.
 ■ A 2006 study showed that more than half of all people 
who died from suicide had alcohol in their blood.
 ■ The rate of discharges for alcoholic liver disease increased 
by 247% for 15–34-year-olds, and by 224% for 
35–49-year-olds between 1995 and 2007.
 ■ Approximately 5% of newly diagnosed cancers and 
cancer deaths are attributable to alcohol, i.e. around  
900 cases and 500 deaths each year.
 ■ Alcohol-related disorders accounted for 1 in 10 first 
admissions to Irish psychiatric hospitals in 2011.
The statement makes a number of recommendations that 
should be implemented immediately to reduce alcohol-
related harm. Many of these recommendations have already 
been outlined in the Department of Health 2012 Steering 
group report on a national substance misuse strategy.2  
They include:
 ■ introducing minimum pricing;
 ■ phasing out alcohol sponsorship of sports events  
and organisations; 
 ■ reducing the number of alcohol outlets;
 ■ strictly controlling low cost sales promotions  
and discounts;
 ■ disseminating guidelines on low risk levels of alcohol 
consumption; and
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‘A quick question’ – alcohol screening 
and intervention 
The Health Service Executive (HSE) did a feasibility test 
for alcohol screening and brief interventions in four 
hospital emergency departments during December 2009 
and February 2010. Staff in the emergency departments 
asked attendees ‘a quick question’ about their alcohol 
use. Discussing the feasibility test, project manager Ruth 
Armstrong, Health Promotion HSE, explained ‘the initiative 
showed that there was good co-operation from the public, 
with 94% of people agreeing to be screened. This shows 
the value of the screening but also helps to reassure staff 
that people were happy to take part.’ This view is further 
supported by a survey1 which found that there is near 
complete support (95% or over) for healthcare professionals 
asking about alcohol consumption where there is a link to 
the condition or treatment. While there is less support in  
the context of routine history taking, support remains strong 
at 89%.
The HSE leaflet, A quick question, was developed as a 
resource for staff undertaking screening and carrying out 
brief interventions with service users during the feasibility 
test. The leaflet was based on the design and content of the 
UK Department of Health (2006) booklet, How much is too 
much.2 The content was designed to encourage people to 
consider drinking less. It contains information on standard 
drinks, risks from drinking alcohol, benefits of cutting down, 
planning your evening, partying safely and where to get 
further information and help. 
Following the results of the feasibility test the HSE developed 
a new national programme for the education and training 
of nurses and midwives in screening and brief intervention 
for problem alcohol use. The framework to support this 
training programme, which was introduced during 2012, 
was developed by the HSE Alcohol Screening and Brief 
Intervention project, Nursing and Midwifery Services 
(ONMSD) and a range of service providers. During 2013, 
the training programme is being rolled out to staff working 
in Tier 1 services as part of the National Addiction Training 
Programme within HSE Social Inclusion services.
Professor Joe Barry, project lead, outlined the purpose of the 
programme: ‘We are all aware of the harm caused by alcohol 
use in Ireland, and the cost to individuals, families and 
society – including the health service. Our health services 
are an ideal setting in which to screen people for alcohol 
use, and offer help to people with problem alcohol use. In 
order for this to happen, staff training is essential, and this 
framework provides the template for this training.’
 ■ labelling alcohol products sold in Ireland to show units of 
alcohol, grams of alcohol per container, calorific content 
and health warnings.
In addition, the policy group proposes a number of actions 
within the health system aimed at reducing damage to 
health caused by alcohol misuse. It proposes that alcohol 
screening and brief interventions be embedded in clinical 
practice and recommends that an integrated model of 
care be developed for treatment of alcohol-related health 
problems. It also recommends that the government allocate 
specific funding for research into alcohol-related harms, 
especially alcoholic liver disease.
In addition to producing further evidence-based policy 
statements, the group
plans on raising awareness of alcohol health harm 
through media campaigns and public meetings, and 
considering how outcomes of the evidence-base can 
be translated into postgraduate medical training and 
education. The policy statements and awareness of 
alcohol health harm will add to the national debate on 
the issue and, importantly, will recommend tangible 
actions to reduce damage to health caused by alcohol 
misuse. (p.5)
(Deirdre Mongan)
1. Royal College of Physicians of Ireland Policy Group on 
Alcohol (2013) Reducing alcohol health harm. Dublin: RCPI. 
www.drugsandalcohol.ie/19732/
2. Department of Health (2012) Steering group report on a 
national substance misuse strategy. Dublin: Department of 
Health. http://www.drugsandalcohol.ie/16908/
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A further screening and brief intervention resource has 
recently been developed in partnership with drugs.ie. An 
online alcohol self-assessment tool with video-based brief 
interventions will be rolled out on the drugs.ie website and 
FaceBook page. Those whose alcohol use is likely to be 
harming their health or increasing their risk of future harm 
are the main target group for this initiative. 
To order copies of A quick question, please go to the 
publications section at www.healthpromotion.ie.  
For more information on the Alcohol Screening and Brief 
Intervention project, please contact Ruth Armstrong at 
ruth.armstrong@hse.ie or go to www.hse.ie/eng/services/
Publications/topics/alcohol/alcoholscreening.html
(Ruth Armstrong, HSE)
1. Ipsos MRBI (2012) Alcohol: public knowledge, attitudes 
and behaviour. Dublin: Health Research Board. www.
drugsandalcohol.ie/18022
2. ESRC Centre for Organisation and Innovation (2006) How 
much is too much? Drinking and you. London: Department 
of Health. Accessed 4 July 2013 at www.sips.iop.kcl.ac.uk/
download.php?id=135
Drugs, alcohol and children’s lives – 
strategy to improve our understanding 
The first implementation report on the National Strategy for 
Research and Data on Children's Lives 2011–20161 presents 
the progress made in the two years since the strategy was 
published in November 2011.2 
The aim of the national research and data strategy is to 
set out a plan to guide and support the development of 
research and data around children’s lives over the lifetime 
of the strategy to ensure that children and young people 
benefit from improved understanding of their lives. The 
strategy works towards the development of a comprehensive 
and co-ordinated approach to the collection, compilation 
and dissemination of research and data on children’s lives 
and facilitates the use of good quality, easily accessible, 
internationally comparable information. 
Strategic objectives
The strategy has five objectives:
A.  to generate a comprehensive and coherent 
understanding of children’s development, preferences, 
needs and appropriate supports and services;
B.  to develop research capacity in the area of children’s 
research and data;
C.  to develop, support and promote good infrastructure in 
the area of children’s research and data;
D.  to improve monitoring and evaluation of children’s 
services at local, national and international level; and
E.  to support a continuum of research and data use within 
policy and practice settings.
Seven actions relating to enhancing research and data on 
drugs and alcohol are listed under strategic objectives A 
and C. It is intended that completion of these actions will 
contribute in turn to completion of Action 37 in the National 
Drugs Strategy 2009–2016: ‘Develop and implement a 
mechanism for early identification, and onward referral 
where appropriate, of substance misuse among under-18 
service users in the wider statutory, community and 
voluntary sectors’.
A10: The Department of Health is tasked with two actions 
to improve, and increase the use of, research and data 
on the topic of alcohol and drugs in relation to children’s 
lives. With the expiry of the mandate of the National 
Advisory Committee on Drugs (NACD) at the end of 2011, 
however, no decisions on new research in the drugs and 
alcohol areas have been made. 
A16: The Health Research Board is responsible for four 
actions – two involve mining ESPAD (European School 
Survey Project on Alcohol and other Drugs) and other data 
sources to produce electronic reports on the interaction 
between drug use and youth offending, and on drug misuse 
among children and young people, and the other two call 
for the publication of an annual digest of national research 
on the topic of drugs in relation to children’s lives and an 
annual report summarising existing survey data on drug 
misuse by children and young people. 
Alcohol>screening>(continued)
drugnet>
Ireland
19
Suboxone feasibility study evaluated
In June 2013 the Department of Health released the results 
of an evaluation of the Suboxone feasibility study which 
started in June 2009.1 The evaluation was carried out 
between October 2010 and February 2011. The objectives 
of the evaluation were to:
 ■ evaluate how patients were selected for participation  
and how they progressed through the study;
 ■ examine how the prescribing and dispensing of 
Suboxone operated in an Irish context;
 ■ consider the practical operation of the feasibility study;
 ■ identify the core elements of the regulatory framework 
needed for the safe use of Suboxone in Ireland.
A variety of methods was used to evaluate the feasibility 
study: analysis of quantitative and clinical records, semi-
structured interviews, and surveys. Not all patients who had 
started on Suboxone could be contacted for consent to be 
included in the evaluation and not all patient records were 
available to be audited. Other stakeholder involvement 
consisted of: eight semi-structured interviews with 
prescribers; 13 semi-structured telephone interviews with 
pharmacists/dispensers; 36 responses to semi-structured 
survey of patients (completed either on-line, on paper 
or over the telephone); two face-to-face interviews with 
patients and two written submissions from patients. The 
clinical notes and dispensing records were reviewed for 41 
patients. There were five key informant interviews. 
A total of 139 patients registered as having received 
Suboxone between 2006 and 2011 were eligible to be 
included in the evaluation. Also included were 11 prescribers 
based in the Drug Treatment Centre Board (DTCB), seven 
prescribing GPs based in other clinics or practices, and 50 
dispensers, the majority (78%) of which were community 
pharmacies. Table 1 outlines the characteristics of those 
included in the evaluation and the reason for exit.
C5: The Department of Health is tasked through the NACD 
with completing a feasibility study to identify data sources 
and research methods to provide a baseline indicator of 
substance misuse among youth at risk. Once established, 
this baseline indicator will continue to be monitored and 
reported on every four years. The hold up in re-mandating 
the NACD has seen a delay in starting this action.
Outcome areas
When developing the national research and data strategy, 
a forensic and systematic analysis was undertaken in order 
to identify research and data gaps and existing data sources 
and to agree priorities. Gaps and priorities were presented 
in the strategy according to five outcome areas, which 
were based on the national service outcomes defined in The 
agenda for children’s services.3 The outcomes are that children 
will be:
1. healthy, both physically and mentally;
2. supported in active learning;
3. safe from accidental and intentional harm, and secure in 
the immediate and wider physical environment;
4. economically secure;
5. part of positive networks of family, friends,  
neighbours and community, and included and 
participating in society.
With regard to outcome 3, risk behaviours such as 
smoking, alcohol and drug use by children, parents and 
others in their broader environment were to be taken into 
account, and crimes committed by, and against, young 
people were also to be included. Preventive, protective 
and remedial services were also to be considered, with a 
particular focus on describing, documenting, identifying and 
evaluating interventions.
Knowledge transfer
Four issues that cut across research and data needs in all 
outcome areas of children’s lives were also identified in  
the strategy:
(a)  development of a national strategic approach to 
information;
(b) improvement of administrative data systems;
(c)  building capacity across all areas of research and data 
development, particularly analytic capability; and
(d)  supporting evidence-informed policy and practice.
With regard to (d), improved dissemination techniques 
and practices, particularly the need for material to be 
available in a timely fashion and for the employment of 
multiple dissemination techniques, were regarded as vital. 
The importance of knowledge transfer was recognised, 
particularly given the complexity of the policy-making 
process. The strategy highlighted the need to link data 
findings more closely to policy and service delivery with, for 
example, the development of short policy briefings tailored 
to the needs of particular communities. Some national 
initiatives already in existence which could support improved 
knowledge transfer were listed, including the Health 
Research Board’s National Documentation Centre on Drug 
Use (www.drugsandalcohol.ie). 
(Brigid Pike)
1. Department of Children and Youth Affairs (2013) National 
strategy for research and data on children’s lives 2011—2016. 
Implementation report: action plan update 2012. Dublin: 
Department of Children and Youth Affairs.  
www.drugsandalcohol.ie/20177 
2. Department of Children and Youth Affairs (2011) National 
strategy for research and data on children’s lives 2011—2016. 
Dublin: Department of Children and Youth Affairs.  
www.drugsandalcohol.ie/16432
3. Office of the Minister for Children (2007) The agenda for 
children’s services: a policy handbook. Dublin: Department 
of Health and Children. Downloaded on 18 July 2013 
from www.dcya.gov.ie/viewdoc.asp?fn=/documents/
Publications/CS_handbook[ENGLISH]lowres.pdf 
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Table 1 Treatment statistics from Suboxone database
Total number of eligible patients N = 139
Males 91 (66%)
Females 48 (34%)
Patients previously treated with methadone 76 (55%)
Total number of treatment episodes N = 149*
Age in years of patients starting each treatment episode
Under 18 6 (4%)
18 to 25 31 (21%)
26 to 35 60 (40%)
36 to 45 39 (26%)
46 and over 13 (9%)
Type of treatment at start of episode
Detoxification 27 (18%)
Opiate maintenance 122 (82%)
Patient outcomes N = 139
Still in Suboxone treatment on 31 Jan 2011 63 (45%)
Exits from treatment (or from treatment episode) 76 (55%)
Reason for exit N = 86
No contact 29 (34%)
Transfer to other opioid substitute 23 (27%)
Treatment successfully completed 19 (22%)
Treatment failure 7 (8%)
Gone abroad 5 (6%)
Deceased† 1 (1%)
Other 2 (2%)
* 10 patients were in Suboxone treatment on two separate occasions, which accounts for the 149 treatment episodes.
† The death was unrelated to Suboxone treatment.
Source: Adapted from Evaluation of Suboxone feasibility study in Ireland, pp. 9, 11 and 13.
Suboxone>study>evaluated>(continued)
Process and limitations of the study
The author noted several issues that may influence the 
results and generalisability of the evaluation. She was 
unable to contact a number of patients who had received 
Suboxone but who were no longer in contact with the 
treatment services. Not all who consented to be included in 
the evaluation could be contacted subsequently. Also, the 
evaluation only included the opinions of those who had been 
involved in the original feasibility study, who therefore might 
already have been positively disposed to the use  
of Suboxone. 
Rationale for commencing Suboxone
The main reasons for prescribing Suboxone, as recorded in 
the clinical notes or dispensing record for 41 patients, were: 
patient had low level of heroin dependence, either having 
never injected, had rarely injected or had a short history of 
heroin use (16, 39%), and patient requested it, or did not 
want methadone (10, 24%) (Table 2). The survey of patients 
showed that the majority (79%) felt that Suboxone was 
the best option for them after discussions with their doctor. 
Of 22 patients previously prescribed methadone, 45% 
had experienced side-effects. Of 11 who had never been 
prescribed methadone, 55% wanted detoxification  
(i.e. to be substance free) rather than to stay on opiate 
substitution treatment. 
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Table 2 Reasons for Suboxone prescription
Records reviewed N = 41
Main drug of dependence
Heroin (injected) 24 (58%)
Heroin (smoked) 10 (24%)
Codeine 4 (10%)
Selection of patients/reason for Suboxone prescription
Low level of heroin dependence 16
Patient requested it, or did not want methadone 10
Treatment for detoxification 6
Previous failed methadone or particular difficulties with methadone 5
Stable 5
Medical need 4
Codeine dependent/oxycodone dependent 5
Previous buprenorphine treatment 3
Unclear 2
Patient experience of Suboxone
The majority of the 36 patients who participated in the 
evaluation were very positive about their experience of 
Suboxone, and many were still on the treatment. They 
reported benefits such as ‘feeling like themselves again, 
reduced cravings’ and returning to a more normal life. On 
the downside, several commented on the difficulties of 
having to be in withdrawal in the early stages of Suboxone 
treatment, which may be a barrier for some individuals. 
Prescribing and dispensing
The evaluation found that there were three different 
protocols on the use of Suboxone in circulation at the time of 
the feasibility study. There was an informal system of training 
and support for doctors who participated in the study. The 
dosage and initiation regimes used ranged from 2mg to 
26mg daily. It was noted that Suboxone is licensed only for 
provision of doses up to 24mg in any one day, and that the 
possibility of less-than-daily dosing was mentioned in only 
one of the protocols, underlining the need for clinicians to 
share their experience in this area.
There were issues highlighted with the prescription form 
for Suboxone, in particular when the prescription did not 
comply with the requirements of the Misuse of Drugs Act. 
Problems reported with the availability of 2mg Suboxone 
tablets caused some difficulties for pharmacists. Patients 
were supplied with a variety of information documents and/
or verbal advice on starting Suboxone. However some of 
the patients reported that they had forgotten what they had 
been told when first prescribed Suboxone, highlighting the 
need for standardised, accessible written information.
Participants were asked about the possibility of diversion 
of Suboxone. The consensus was that there was little or 
no diversion due to the tight controls and stability of the 
patients. In the patient survey, 76% reported that Suboxone 
was not available on the street. 
Costs
This evaluation discusses the 2007 report done by the 
National Centre for Pharmacoeconomics (NCPE) for the 
expert group.2 That report concluded that on current 
evidence Suboxone could not be considered cost effective 
for patients attending HSE clinics unless opiate abstention 
rates were at least 10% higher with Suboxone than with 
methadone. The evaluation noted that the low cost of 
methadone makes comparing costs with any other treatment 
difficult. It was felt that societal costs had not been factored 
into the NCPE report and that, although more expensive 
than methadone, providing Suboxone to certain patients for 
whom there is a clear rationale would have economic and 
societal benefits.
Regulating provision
There was no clear consensus among prescribers or key 
informants as to what was the most appropriate mechanism 
to regulate provision, as each had both positive and negative 
aspects. The issues discussed were:
 ■ having a cap on the number of patients who can be 
prescribed Suboxone;
 ■ having a fixed budget cap (rather than a cap  
on patients);
 ■ restricting prescribing to certain groups of prescribers 
and/or patients;
 ■ negotiation with the relevant pharmaceutical company 
on price.
Conclusions and recommendations
The evaluation concludes that ‘Suboxone has been used in 
this feasibility study with a wide range of patient groups, for 
whom it has the potential to be beneficial and it appears to 
offer a number of advantages over methadone’ (p.44). In 
considering future safe provision of Suboxone in Ireland, it 
makes a number of recommendations (pp.44–47), which are 
summarised below. 
1. The Suboxone Expert Group discuss and agree  
interim criteria for who should be eligible for  
Suboxone treatment. 
2. If Suboxone prescribing is restricted to certain groups/
subjected to certain criteria in future, audit and reporting 
processes should be established to add weight to the 
criteria and enable any prescribing patterns that are 
unusual or fall outside the criteria to be identified  
and explored.
3. National guidelines on the use of Suboxone across all 
prescribing and dispensing settings should be developed. 
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4. Standard patient information resources should be used 
across all settings.
5. Prescriptions for Suboxone should be designed for clarity 
and avoidance of ambiguity. 
6. The system for remuneration of Suboxone in future 
should be incorporated into remuneration systems 
for opioid treatment services and should be clearly 
communicated to prescribers and dispensers (including 
any future prescribers and dispensers).
7. Clarification of the ethical and legal position of 
pharmacists and clinics in relation to the various options 
for coping with stock shortages should be provided. 
Professional guidance should be prepared in relation to 
the appropriate management of such situations.
8. Arrangements should be made for the appropriate 
management of Suboxone stock which may be left in 
pharmacies where they no longer have any patients  
on the drug.
9. Suboxone should be made available through more  
than one wholesaler to reduce the likelihood of  
stock shortages.
10. Suboxone initiation and prescribing should be restricted 
to those with suitable expertise and training. 
11. Suboxone dispensing should be restricted to those with 
suitable expertise and training. 
12. There is a need for a mechanism for prescribers to share 
and discuss their experiences with Suboxone (and in  
the management of opioid dependence in general, 
including methadone). 
13. Engagement should take place with the pharmaceutical 
company marketing Suboxone in order to consider price, 
budget projections and shared-risk arrangements for any 
future use of Suboxone.
14. Any future consideration of the cost-effectiveness of 
Suboxone should take into account the full range of 
potential benefits from successful treatment of opioid 
dependence, including reduced social costs.
(Suzi Lyons)
1. Fitzgerald N (2011) Evaluation of Suboxone feasibility  
study in Ireland. Dublin: Department of Health.  
www.drugsandalcohol.ie/19976
2. National Centre for Pharmacoeconomics (2007) Economic 
evaluation of the use of Suboxone for opiate addiction. 
Summary. Dublin: National Centre for Pharmacoeconomics. 
www.ncpe.ie/wp-content/uploads/2007/12/Suboxone-
summary.pdf
Proposed regulatory framework  
for buprenorphine/naloxone products  
in Ireland
The drug Suboxone, a combination of buprenorphine 
and naloxone, was licensed for use in 2006 in Ireland as 
an alternative to methadone for opiate dependency. In 
2007 the Department of Health set up an expert group to 
examine the regulatory framework for products containing 
buprenorphine/naloxone and buprenorphine-only.1 The 
expert group considered a number of relevant documents, 
including the evaluation of a feasibility study on the use 
of Suboxone in Ireland.2 (That evaluation is reviewed 
on p.19 of this issue.) The report of the expert group is 
now available.3 The terms of reference of the group are 
outlined below, with a summary of its deliberations and 
associated recommendations.
1.  In the context of the product authorisation for Suboxone 
issued by the European Medicines Agency, to consider 
and make a recommendation as to whether the general 
regulation of relevant professions provides a sufficient 
regulatory framework for the prescription and dispensing  
of buprenorphine/naloxone, or buprenorphine-only  
products in Ireland.
The group concludes that the regulations and guidelines 
for the prescribing and dispensing of methadone 
can also apply to buprenorphine/naloxone, or 
buprenorphine-only products.
2.  To consider and make recommendations if appropriate as 
to which if any elements of the methadone protocol should 
apply to Suboxone, and if so how they could apply in 
practical terms. 
The group concludes that the Methadone Protocol Scheme 
can also apply to the prescribing and dispensing of 
buprenorphine/naloxone or buprenorphine-only products, 
and that the details of patients receiving these products 
should be recorded on the Central Treatment List. Other 
general recommendations include having consistent and 
uniform guidelines for prescribing and dispensing these 
products, that the current methadone prescription form 
should be adapted for them, the need for co-ordinated 
multi-disciplinary training, and a system of clinical 
governance and audit for GPs and pharmacies. 
3.  To consider and make recommendations if appropriate 
as to whether and if so how Suboxone should be made 
available to particular client groups and/or settings in an 
Irish context, taking into account the work done by the 
NACD and taking into account the cost of this treatment. 
The group concludes that methadone is the drug of 
first choice for treating opiate dependency, but that 
buprenorphine/naloxone may be appropriate for some 
patient cohorts in certain circumstances, as follows:
 ■ patients already receiving treatment with  
buprenorphine/naloxone;
 ■ patients with a specific medical condition where 
methadone is contraindicated, for example prolonged 
QT interval;
 ■ patients who have never been prescribed methadone 
before, especially young patients, where detoxification is 
a primary goal of treatment; 
 ■ patients whose main problem drug is codeine or another 
pharmaceutical opiate;
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 ■ patients who the prescriber believes to be stable for  
at least six months, particularly in regard to  
employment or education, and committed to  
compliance with the treatment.
After individual patient risk assessment, less-than-daily dosing 
can be considered, with frequency down to every second 
day or even to three times per week after a satisfactory level 
of stabilisation. The total amount of Suboxone given on any 
one day must not exceed the maximum of 24mg authorised 
by the European Medicines Agency. 
The group states that the economic factors involved were 
outside the scope of their deliberations but were relevant to 
the establishment of a buprenorphine/naloxone treatment 
protocol and should be considered. These included:
 ■ findings of the economic evaluation done by the National 
Centre of Pharmacoecomomics in 20074 which found 
that Suboxone and buprenorphine-only could not be 
considered cost effective when compared to methadone 
in clinics or in the community;
 ■ generic pricing discussions between the HSE and  
the manufacturer;
 ■ issues around HSE clinics which have their own budgets 
and consistency of treatment; and
 ■ contractual implications in relation to prescribing and 
dispensing for both GPs and pharmacists.
The group advises that the recommendations be reviewed 
within two years of the date on which they were given to the 
Minister, to allow for new research and evidence to be taken 
into account.
4.  To consider and make recommendations if appropriate 
as to whether and if so in what way buprenorphine-only 
products should be available in Ireland. 
The group is not aware of any buprenorphine-only products 
being marketed in Ireland to treat opiate dependence. 
They acknowledge that, while not authorised in Ireland, 
buprenorphine-only products may be prescribed for 
pregnant women in certain circumstances, and with 
appropriate advice and warning. They advise that if a 
buprenorphine-only product were to be prescribed and 
dispensed in Ireland, it should be done with extreme  
caution due to the high risk of diversion and potential for  
use by injection. 
5.  To consider any legal advices received in relation to the 
above matters.
After taking legal advice, the group decided that if 
buprenorphine/naloxone or buprenorphine-only products 
were to be used in Ireland then the appropriate changes will 
have to be made to the misuse of drugs legislation and the 
regulations for the prescription and supply of methadone. 
(Suzi Lyons)
1. Long J (2007) Suboxone licensed in Europe. Drugnet Ireland, 
(22): 25. www.drugsandalcohol.ie/11396
2. Fitzgerald N (2011) Evaluation of Suboxone feasibility  
study in Ireland. Dublin: Department of Health.  
www.drugsandalcohol.ie/19976
3. Expert Group on the Regulatory Framework (2011) 
Recommendations of the Expert Group on the Regulatory 
Framework for products containing buprenorphine / naloxone 
and buprenorphine-only for the treatment of opioid dependence. 
Dublin: Department of Health. www.drugsandalcohol.
ie/19977
4. National Centre for Pharmacoeconomics (2007) Economic 
evaluation of the use of Suboxone for opiate addiction. Dublin: 
National Centre for Pharmacoeconomics. www.ncpe.ie/wp-
content/uploads/2007/12/Suboxone-summary.pdf
Regulatory>framework>(continued)
Clinical practice guidelines for 
prescribing methadone in pregnancy
New clinical practice guidelines on safe and effective 
prescribing of methadone for pregnant women in maternity 
hospitals were jointly published in April 2013 by the Institute 
of Obstetricians and Gynaecologists and the Health Service 
Executive. Based on an earlier document used by the three 
Dublin maternity hospitals, these new guidelines were 
developed after a wide-ranging review of the literature and 
consultation with key stakeholders. 
The document recommends that all pregnant women with 
problem opiate use should attend a specialist or high-risk 
antenatal clinic. If this is not possible, the woman should 
attend the same clinic throughout her pregnancy to ensure 
continuity of care.
The guidelines work through various common clinical 
scenarios and issues around admission and discharge. They 
are designed to guide clinical judgment, not replace it. 
Clinical Scenario 1: Pregnant women admitted and known 
to be on prescribed methadone from medical record or 
verbal history.
 ■ Their methadone provider should be contacted to 
confirm details. The hospital medical team should ensure 
that methadone is prescribed in a timely manner.
Clinical Scenario 2: Pregnant women admitted with a take–
away methadone supply.
 ■ Women should be advised not to bring supplies of take-
away methadone into hospital. If they do, the methadone 
must be sent to the pharmacy to be destroyed.
Clinical Scenario 3: Pregnant women admitted to hospital 
self-reporting heroin use but not registered with the addiction 
services or a prescribing GP.
 ■ This group of women need to be assessed and treated in 
a timely manner, given that opiate withdrawal carries the 
risk of pre-term delivery and foetal death. It is advisable 
to seek guidance from the local addiction services and 
also to confirm that the woman is opiate dependent. The 
management of initiation of any methadone treatment 
should be closely monitored.
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Clinical Scenario 4: Pregnant women admitted looking  
for a prescribed dose of methadone out of hours and  
known to be on prescribed methadone from medical record  
or verbal history.
 ■ As methadone cannot be administered on an out-patient 
basis, the woman must be admitted, then up to a 
maximum of half her current dose prescribed.
Intoxicated pregnant women 
 ■ Because of the risk of overdose, methadone must not be 
dispensed to a woman who may be intoxicated until they 
have been medically assessed.
Vomiting in pregnant women on methadone- 
maintenance treatment
 ■ Vomiting may not be related to the methadone, so other 
possible causes should be investigated, e.g. hyperemesis 
gravidarum. Depending on the time lines and amount 
vomited, a proportion of, or all of the dose may be re-
administering.
Discharge of methadone-maintained women
 ■ All details of the woman’s methadone prescription should 
be sent to the prescriber in the community (either clinic 
or GP). Women should not be discharged with supplies 
of methadone from hospital stock or a prescription for 
methadone or benzodiazepines. 
Peripartum pain management
 ■ Women on methadone treatment should be offered, if 
required, the same pain relief options as other women 
for labour or post-partum pain, as maintenance doses 
of methadone do not provide adequate pain relief. They 
should be reassured that there is no evidence that the 
administration of opiates for pain relief leads to relapse, 
however they may require higher doses to provide 
effective relief.
Breastfeeding
 ■ Women who are stable on methadone and have no 
contra-indications should be encouraged to breastfeed if 
they wish. However if the woman is on other medication, 
e.g. benzodiazepines, advice should be sought.
Methadone dosing in pregnancy
 ■ This can be a difficult area to manage, particularly 
because of the complexities of pregnancy-associated 
pharmacokinetic changes which have been shown to 
reduce the concentration of methadone in the blood. 
Some women may wish to reduce their dose in order 
to reduce the risk of neonatal abstinence syndrome in 
their infant; however, there is no evidence to support 
this theory. Each woman’s dose, her tolerance and its 
effectiveness should be monitored and titrated closely 
during the pregnancy. Because of the risk of relapse and 
the subsequent risk to the foetus, detoxification from 
methadone is not recommended during pregnancy.
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Key recommendations  
(reproduced from p.3 of Clinical practice guideline)
1. Methadone maintenance treatment is the treatment 
of choice for opioid-dependent pregnant women. In 
adequate doses, methadone provides stability for the 
woman during pregnancy, avoiding repeated cycles of 
intoxication and withdrawal that may adversely affect 
the foetus. 
2. Withdrawal from opioids can cause foetal death and 
preterm delivery. It is important that women who 
report illicit opiate use are assessed and treated in a 
timely manner. 
3. Clear communication between maternity hospitals 
and local addiction services is required, particularly in 
relation to methadone doses and admission/discharge 
of methadone-maintained women. 
4. Initiation of methadone may be required in a maternity 
hospital to avoid obstetric complications of opioid 
withdrawal. Careful initiation is required, as the highest 
risk of overdose mortality is in the first two weeks on 
methadone treatment. 
5. A validated scoring tool should be used to assess  
signs of opioid withdrawal in opioid-dependent 
pregnant women. 
6. Opioid-dependent pregnant women are at risk of 
under-treatment of peripartum pain. 
7. Breastfeeding should be encouraged in women who 
are stable on methadone maintenance treatment unless 
there are other medical contraindications. 
8. The maternal methadone dose should be  
individually adjusted to control maternal craving  
or withdrawal symptoms. 
(Suzi Lyons)
1. Institute of Obstetricians and Gynaecologists and Health Service Executive (2013) Clinical practice guideline: methadone 
prescribing and administration in pregnancy. Dublin: Institute of Obstetricians and Gynaecologists and Health Service Executive 
www.drugsandalcohol.ie/20188
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Stakeholder views on housing-led 
services for homeless people
The Simon Community commissioned exploratory research 
to assess whether housing-led services would represent an 
improvement on existing practice in delivering services to 
homeless people in Ireland. The results of that research have 
now been published.1 According to the authors, ‘housing-
led services are “housing-led“ because the first thing they do 
is place a person who is homeless into permanent or settled 
accommodation and because the support they provide is 
mainly delivered within that accommodation. …A housing-
led service is also characterised by following a specific 
philosophy that promotes choice and control for people who 
are homeless’ (p.8); and ‘housing-led services follow a harm 
reduction approach with a recovery orientation’ (p.9). 
Fieldwork and data collection for this research included nine 
focus groups with 27 participants (21 males) who were 
or had recently been homeless, including 19 people who 
were or had been entrenched rough sleepers, i.e. people 
with high and multiple support needs who had sustained 
experience of sleeping rough. In addition, data were 
collected from 17 service providers working with the Simon 
Communities. Fieldwork with these groups was spread 
across Cork, Dublin, Dundalk, Letterkenny and Sligo. In 
addition, seven organisations working in the homeless sector 
responded to a detailed questionnaire. Emerging findings 
from all fieldwork and collation of data were discussed with 
participants from across government and the homeless 
sector prior to publication of the report. 
Awareness of what the housing-led approach means was 
reported as high among service providers. Service users 
were not as aware of what the approach entailed, but, when 
it was explained, the idea of having their own ‘home’ was 
popular among them. There was consensus among service 
providers that simply providing housing to people with long 
histories of homelessness who might have high support 
needs, such as mental health and addiction issues, was 
unlikely to result in positive outcomes. Appropriate types and 
levels of support with housing were deemed to provide an 
effective response. 
The main concern expressed by all participants was the 
insufficient supply of adequate and affordable housing for 
housing-led services to work effectively. Difficulty in accessing 
social housing due to a lack of new supply and barriers in 
the process of allocating the existing supply were cited as 
particular limitations. 
Concerns were also expressed by all participants about 
the affordability of housing in the private rented sector. 
Restrictions on the amount paid to social welfare claimants 
through rent supplement meant that people were unable to 
meet the relatively high rents being charged in the private 
sector without having to ‘top-up’ from the remaining portion 
of their welfare payments. Also, the poor standard of some 
of the affordable private rented accommodation was cited 
as a concern. It was reported that some private landlords 
were reluctant to accommodate people with a history of 
homelessness as these people were perceived to be ‘risky’ 
tenants. In addition, in a social context where the need for 
private rented accommodation is growing among  
the general population, people with experience of 
homelessness are often the least preferred tenants by  
some private landlords. 
People with experience of homelessness expressed a 
preference to be housed in social housing, which they 
believed provided more flexibility and stability in the longer 
term and was more suitable to their needs; this view was 
shared by service providers. These views are pertinent given 
that the housing-led approach is dependent, for the most 
part, on the immediate provision of a settled home in the 
community. 
Some attractive features of the housing-led approach are 
that it offers people independence, choice and control to a 
greater extent than alternative models. Participants felt that 
while most people who become homeless in Ireland might 
wish to live independently in their own home with modest 
support, housing-led services were not the answer for people 
with high-support needs. Factors cited to elaborate on this 
view included a belief that some people who had experiences 
of long-term homelessness were also affected by their 
experiences in industrial schools, which in some cases led to 
them experiencing institutionalisation. It was felt, particularly 
by those with experience of homelessness that living 
independently without the appropriate level of support and 
access to meaningful daytime activities such as employment, 
training and education could lead to mental illness and/or 
relapse to problematic use of alcohol and drugs. 
Joint working through case management to offer a package 
of supports is often seen as an integral part of delivering an 
effective housing-led model. The views expressed by service 
providers suggest that access to welfare benefits and to 
health and social services, as well as to specialist addiction 
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and mental health services, is currently restricted for people 
experiencing homeless. These restrictions have arisen due to 
changes to the levels and eligibility rules for welfare benefits. 
Restricted access to health and other social services, primarily 
due to cuts in service provision, is seen to compromise 
efforts by the homeless sector to resettle homeless people; 
people with experience of homelessness and who are trying 
to live independently in the community are also adversely 
affected by these restrictions. Service providers also reported 
problems around mental health services not working with 
people with drug and alcohol problems and alcohol and 
drug services not working with people with mental health 
problems. These concerns regarding the fragmented nature 
of service provision may have implications for the inclusion of 
an integrated package of services for homeless people as part 
of the current Housing First Demonstration Project (HFDP) 
being operated in Dublin, as, ‘all forms of housing-led 
services are reliant to at least some degree on joint working 
with the welfare systems and health, social care and mental 
health services’ (p.27). 
Service providers were sceptical of what they perceived 
as the official policy view, that housing-led services could 
be delivered as low-cost, low-intensity and short-term 
interventions to assist homeless people. On the contrary, 
they emphasised that the homeless population was not an 
homogenous group, rather homelessness was experienced 
by different people for different reasons and with different 
types and levels of support needs. There was consensus 
among service providers and homeless people that the sector 
needed to retain a broad mix of options to cater for the 
diverse needs of homeless people. 
While the idea of housing-led services in Ireland was 
generally welcomed and endorsed by participants in this 
research, it is clear that from both standpoints, housing-led 
services are not currently seen as a panacea for the problem 
of homelessness and its associated issues. The reservations 
expressed by participants centre around the view that 
responses to homelessness involve more than just providing 
housing in the form of ‘bricks and mortar’. Effective 
responses need to include housing alongside appropriate 
support, especially for people with high-support needs. 
In addition, participants in this research cautioned against 
providing housing as an individual unit of residence for some 
homeless people, instead it was suggested that communal 
residential housing with appropriate support might be 
more suitable for people with personal biographies that 
include sustained periods of time spent in institutions and 
homelessness. The divergent views expressed by participants 
in this exploratory study are not wholly different from the 
academic perspective which underpins a critical analysis of 
the suitability of the housing-led approach as a ‘solution’ 
to the often intractable problem that is homelessness. 
According to the authors, ‘the consensus of the academic 
research is broadly similar – housing-led services are very 
effective at ending homelessness among people with high 
needs and sustained experience of homelessness, but that 
while some other gains in well-being are being achieved, 
these services are not necessarily fully meeting all associated 
support needs or successful with everyone they try to work 
with’ (p.31). 
(Martin Keane)
1. Pleace N and Bretherton J (2013) Finding the way home: 
housing-led responses and the homelessness strategy in  
Ireland. Dublin: Simon Communities of Ireland.  
www.drugsandalcohol.ie/20183
Youth homelessness in Dublin: key 
findings from a six-year study
Key findings from the only qualitative longitudinal study of youth 
homelessness undertaken in Ireland were published July 2013.1 The study 
covered a six-year period and included three phases of data collection 
with young people experiencing homelessness in Dublin. Two earlier 
publications reported on phase 1 and phase 2,2 and were covered in 
past issues of Drugnet Ireland.3 This article summarises the profile and 
characteristics of the participants and describes some of the key findings 
from the three phases, as reported in the latest publication. 
Phase 1: Baseline profile and characteristics (September  
2004 – January 2005)
Forty young people, 23 males and 17 females, aged between 14 and 
22 years, were interviewed at baseline. Their early childhood was 
characterised by poverty, traumatic life events and household conflict and 
instability. They reported deteriorating relationships with their parents 
during their early to mid-teenage years. Eighteen of the 23 young men 
left school at or before the age of 15; the young women remained longer 
in education, with 11 of the 17 attending school at baseline interview. 
Twenty-five of the young people were living in under-18s emergency 
or short-term hostel accommodation, and most of the others were 
accommodated in other short- or medium-term accommodation; three 
were in prison and two were sleeping rough. Eleven reported being 
homeless for between two and four years, and eight for five years or more. 
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Those with longer homeless histories reported problematic 
and dependent patterns of alcohol and/or drug abuse, with 
half (13 males and 7 females) reporting use of heroin at 
some stage. ‘Drug use escalated for practically all young 
people as their “careers” in homelessness progressed and 
this pattern of consumption was especially apparent among 
those who moved constantly between hostels targeting the 
under-18s’ (p.22). 
Twenty of the young men and eight of the young women 
had been charged with at least one criminal offence. 
According to the authors, ‘their accounts demonstrate 
the interconnectedness of homeless, drug and criminal 
“careers”’. …However, few of the young people were 
heavily involved in drug use and even fewer had records of 
offending at the time they first left home’ (pp.22–23). 
Becoming homeless
Almost half the 40 young people (9 males and 10 females) 
first experienced homelessness at age 14 or under, and 12 (9 
males and 3 females) at age 15. Although most recalled their 
own unique account of becoming homeless, the authors 
identified three broad, and overlapping pathways that 
characterised their entry into homelessness: 
 ■ a history of state care;
 ■ family instability and family conflict;
 ■ problem behaviour and negative peer associations. 
Sixteen of the young people had experience of the state 
care system, mainly through foster care, with many reported 
multiple placements leading to instability and disruption in 
their young lives. Although many experienced a traumatic 
childhood in the family home, this did not prevent them 
from carrying feelings of resentment about their separation 
from their parents and siblings. 
For the majority of the young people, parental conflict and/
or marital breakdown featured prominently in the events 
leading to their first homeless experience. Parental drug or 
alcohol abuse was reported by 16 and physical abuse by an 
adult in the home was experienced by 18 young people. 
They also reported how their own behaviour, including using 
alcohol and drugs and staying out late with friends, often led 
to disagreement with their parents. Most of them admitted 
having been ‘rebellious’ in their early teens; however, 
for many the adverse circumstances of the family home 
contributed to their vulnerability. According to the authors, 
Furthermore, by the time young people found 
themselves out of home for the first time, their 
experiences of a number of key institutions (including the 
family, school or State care) had been overwhelmingly 
negative. Consequently, at a relatively early age, a 
large number were living outside, or marginal to, the 
structures that play a critical role in preparing young 
people for the transition to adulthood. (p.24) 
Phase 2: Homeless exits and continued homelessness 
(September 2005 – August 2006)
Thirty of the young people (16 males and 14 females) were 
re-interviewed at phase 2 of data collection. Seventeen 
(5 males and 12 females) had secured greater stability 
in their accommodation at this juncture, approximately 
12–18 months since baseline. Seven were in transitional/
supported housing, six were living at home, three were in 
foster or residential state care and one was in private rented 
accommodation. Thirteen (11 male and 2 female) remained 
homeless; five were in prison, four in adult hostels, two were 
sleeping rough, one was in a residential drug treatment 
programme and one was in temporary accommodation and 
awaiting sentencing in the criminal justice system. As these 
figures illustrate, a far greater number of female participants 
had exited homelessness by phase 2 of the study. 
Phase 3: Sustained exits and prolonged homelessness 
(September 2009 – August 2010) 
Twenty eight of the young people (15 males and 13 females) 
were re-interviewed at phase 3 of data collection. Fifteen (3 
males and 12 females) had exited or sustained an exit from 
homelessness, of whom nine (including eight females) were 
living in the private rented sector, one male was in local 
authority housing, one female was living in an independent 
flat, one female was living in their partner’s home, one 
female was in a residential aftercare facility and one female 
and one male were in the family home. As the authors point 
out: ‘Consistent with the patterns identified at phase 2, far 
more females than males had exited or sustained an exit 
from homelessness. Gender therefore remains significant in 
the exiting patterns of young people…’ (p.25).
This study has generated an in-depth and rich understanding 
of young people’s routes into, through and out of 
homelessness. Its insights should provide food for thought 
for those charged with designing and implementing policy 
and practice to prevent youth homelessness. It is clear from 
the testimony of the participants that the key institutions of 
socialisation that we rely on to bring security, development 
and identity to our young people – the family, the education 
system and the state care apparatus – can fail miserably 
at times. When these institutions fail and young people 
end up homeless and vulnerable, measures to disrupt this 
experience and facilitate their quick exit from homelessness 
are key to their regaining stability. In this regard, the 
successful work done to ensure the exit from homelessness 
of all but one of the young women in this study has to be 
acknowledged. On the other hand, policy and practice 
also needs to acknowledge that it appears much harder for 
young men to exit homelessness and the longer they remain 
in this condition the more hazardous their lives become, 
i.e. criminal convictions and the more marginal they remain 
from society. 
(Martin Keane) 
1. Mayock P and Corr ML (2013) Young people’s homeless 
and housing pathways: key findings from a 6-year qualitative 
longitudinal study. Dublin: Stationery Office.  
www.drugsandalcohol.ie/20191.
2. Mayock P and Vekic K (2006) Understanding youth 
homelessness in Dublin city: key findings from the first phase of 
a longitudinal cohort study. Dublin: Stationery Office.  
www.drugsandalcohol.ie/6200; and Mayock P, Corr ML 
and O'Sullivan E (2008) Young people's homeless pathways. 
Dublin: Homeless Agency. www.drugsandalcohol.ie/4239.
3. Keane M (2007) Research on youth homelessness in Dublin. 
Drugnet Ireland, (21): 21–22; and Keane M (2009) The 
process of youth homelessness. Drugnet Ireland, (29): 18. 
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Mapping the empirical research  
base of youth work: learning from 
international practice
An estimated 312,615 young people aged between  
10 and 24 participated in youth work activities in Ireland 
during 2011, according to a recent report prepared  
for the National Youth Council (NYCI).1 This figure represents 
43.3% of this age cohort nationally; 54% of the participants 
were female and 53.3% were believed to be socially or 
economically disadvantaged.
Against this background, the first systematic map of 
youth work research internationally was published in June 
2013.2 This work was commissioned by the Department 
of Children and Youth Affairs to inform the development 
of a ‘youth policy framework’. The report cites the EPPI-
Centre’s definition of a systematic map as ‘a classification 
and description that aims primarily to illustrate the kinds of 
studies that exist’ in a specific area (p.4). This article briefly 
describes the methods of the mapping process and the key 
elements of the design of youth work interventions. 
Search strategy
Potential studies were drawn from 11 bibliographic 
databases, 10 relevant websites, contents pages of key 
journals, reference lists of systematic reviews, and input from 
key informants and experts. In total, 175 studies published 
between 1976 and 2011 are included in the final report; 
69% of these are from the US. 
Inclusion criteria
Studies were included if they focused on young people aged 
10–24, professionals working with young people, or parents 
of young people engaged in youth work activities. Studies 
that focused on positive futures for young people, that 
reported evaluations of effectiveness, delivery and outcome 
measurement were included. 
Profile of the 175 studies included 
The majority (68%) of the 175 studies were published as 
peer-reviewed journal articles; 50% evaluated the impact 
of youth work programmes, focusing on ‘what works’, and 
20% evaluated the process of delivering a programme, 
focusing on ‘how it works’. One third were designed as 
case studies and 23% were cross-sectional designs; both 
approaches collected data at one point in time, e.g. 
following participation in programme activities. In addition 
to primary studies, 33 non-systematic and three systematic 
reviews were included. Methods of data collection used 
in the studies included interviews with individuals (41%), 
focus groups (17%), closed-question surveys (38%) and/
or validated scales (21%), and observation of people and 
activities (19%). Some studies combined data collected by 
more than one method, e.g. interviews and surveys. 
Theories, aims and activities of youth work 
The most commonly cited theoretical approach among 
the 93 studies that evaluated outcomes was the ‘positive 
youth development’ theory. According to the authors, 
this school of thought asserts that ‘for young people to 
meet developmental targets, they need to be engaged in 
activities delivered in settings that are safe, supportive and 
foster meaningful relationships. …theories of positive youth 
development could underpin a range of different youth 
work activities and still be considered effective in producing 
desired outcomes’ (p.23).
The next most commonly cited theoretical approaches 
underpinning youth work programme were the ‘socio-
ecological model’ and the ‘empowerment model’. The 
former model seeks to design programmes that address a 
combination of individual and environmental factors through 
focusing on the dynamic relationship between young people 
and others within the wider context of their lives. The latter 
model emphasises the design of programmes to assist young 
people to develop a greater understanding of power and 
control in their lives, socially, politically and economically, 
and to support them to become consciously and critically 
engaged with society through a range of measures and 
activities. Both models are more focused on desired 
outcomes for young people than on specific activities and 
both emphasise the interaction between young people and 
wider society. In contrast, the positive youth development 
model is more about creating the right conditions to 
improve personal development outcomes for young people. 
The personal and social development of young people was 
reported as the primary aim in over twice as many included 
studies as any other aim (Table 1). In Ireland, the Youth Work 
Act 2001 defines youth work as: 
A planned programme of education designed for the 
purpose of aiding and enhancing the personal and 
social development of young people through their 
voluntary involvement, and which is complementary 
to their formal, academic or vocational education and 
training and provided primarily by voluntary youth 
work organisations.
Leisure, recreation and arts activities were reported by 
most studies included in the mapping process (Table 1). 
The nature of youth work in Ireland is quite similar to that 
reported from international research, with the vast majority 
(80%) of youth work organisations in Ireland providing 
recreational, arts and sports-related activities.1 
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Table 1 Aims and activities of youth work reported in 93 studies focusing on outcomes 
Aims Number of studies 
reporting as primary aim
Activities Number of studies 
reporting activites
Personal and social 
development
71
Leisure and recreation 
39
Social change 28 Arts, drama, music 28
Safety and well-being 26 Volunteer and service 26
Education and career 24 Sports 25
Contribution to society 20 Informal learning 22
Social action 15
Work 7
Source: Dickson et al. (2013)
Outcomes and measures in youth work
The NYCI report focused mainly on the impacts of youth work, specifically the economic benefits, i.e. crime reduction, rather 
than on outcomes and the outcome measures employed. However, the report listed (on p.91) some of the main outcomes of 
youth work highlighted in an earlier study,3 which are summarised below:
 ■ enhanced personal attributes and qualities; 
 ■ opportunities for more positive associations with people; 
 ■ personal development; 
 ■ enhanced positive and pro-social behaviour; 
 ■ development of practical skills, for example making decisions, organising, planning; and 
 ■ information, advice and advocacy in relation to health, relationships, sexuality. 
These outcomes are not dissimilar from those reported in international research and reflect the emphasis on improving 
personal and social development, which was reported in almost twice as many studies as other outcomes, such as  
improving civic engagement and reducing risky behaviour (Table 2). 
Table 2 Outcomes and measures of youth work reported in 93 studies evaluating effectiveness in youth work
Outcomes* Indicators Number of studies
Relationship with others Positive relationships with adults, peers; pro-social skills, 
leadership skills, decision-making skills, empowerment
66
Sense of self Personal development, self-esteem, self-efficacy,  
self-confidence, identity
64
Community and society Civic engagement, bonding with community,  
partnership working
36
Health and well-being Reduced substance use, reduction of risky behaviours, making 
healthy choices, diverted from crime, positive mental health
36
Values and beliefs Future aspirations, pro-social values, healthy attitudes 30
Formal education and training Academic achievement, commitment to learning 27
* Outcomes are not mutually exclusive, reported overlap between studies
Source: Dickson et al. (2013)
This review of the literature shows that there are many similarities between the practice of youth work in Ireland and 
international research on the key components in design and evaluation. However, further work is needed to evaluate the 
outcomes of youth work in Ireland against international benchmarks and to assess the effectiveness of using generic youth 
work models, i.e. personal and social development, to target the most at-risk young people. 
(Martin Keane) 
1. Indecon International Economic Consultants (2012) Assessment of the economic value of youth work. Report prepared for the 
National Youth Council. Dublin: National Youth Council of Ireland. www.drugsandalcohol.ie/19045
2. Dickson K, Vigurs CA and Newman M (2013) Youth work: a systematic map of the research literature. Dublin: Department of 
Children and Youth Affairs. www.dcya.gov.ie/viewdoc.asp?DocID=2720
3. Devlin M and Gunning A (2009) The purpose and outcomes of youth work: report to the Interagency Group. Dublin: Irish Youth Work 
Press. www.youthworkireland.ie/youth-work-centre/resources
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Profile of attendees at MQI health 
promotion unit
Merchants Quay Ireland (MQI) has published the profile 
of a cohort of people attending its Health Promotion Unit 
(HPU) needle exchange.1 The main objective of the HPU is 
to minimise the risks associated with injecting substances 
by providing sterile injecting equipment and information 
and instruction on safe injecting techniques. Data were 
collected from 338 attendees using an instrument developed 
specifically to meet the information needs of the HPU in MQI 
and included items from internationally validated survey 
instruments and items fashioned specifically for the present 
study. Staff in the HPU collected data on socio-demographic 
characteristics, substance use, injecting risk behaviour and 
blood-borne virus (BBV) status and treatment. This article 
presents some of the key findings in the report under the 
four domains of enquiry. 
Socio-demographic characteristics
A total of 338 participants took part in the study, including 
290 males (85.8%). Participants ranged in age from 20 to 
59 years; the majority were in the 20–34-year age group. 
Participants included 19 different nationalities; the majority 
297 (88%) were Irish nationals. Approximately a third 
of the cohort reported living in conditions which can be 
categorised as homeless (Table 1).
Substance use
Participants who used heroin were found to consume an average of 2.35 bags per day, and to spend an average of €45.72 per 
day on the drug. Route of administration for the vast majority of heroin users was injecting, 245 (84.4%); 34 (11.7%) reported 
both injecting and/or smoking heroin and six (2.7%) reported smoking only. 
There were no differences between the genders for most substances used. Where differences did arise, proportionately more 
females than males reported using prescribed methadone (73% v 46%), illicit benzodiazepines (25% v 17%) and prescribed 
benzodiazepines (23% v 14%) (Table 2). 
Seventy-five per cent reported using two or more substances in the last month (current use). Thirty per cent (102) reported 
using two substances in the past month, the most frequent combination being heroin and methadone, used by 49 (48%) of 
the sub-sample. Almost 9 out of 10 users of prescribed methadone reported using heroin. Heroin users who did not report 
using methadone were reported to consume higher average amounts of heroin per day, to spend more money on heroin per 
day and to use heroin on the greatest number of days in the past month. 
Table 1 Accommodation status during last seven days
Accommodation status n %
Own/rented home 160 47
Staying with friends/family 73 22
Emergency accommodation 67 20
Sleeping rough 15 4
Supported temporary accommodation 12 4
Long-term supported housing 11 3
Source: Jennings (2013) 
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Injecting risk behaviour
The report states that 329 (97%) of the cohort were currently injecting substances. Almost three quarters of the current 
injectors who provided a response reported that they had not shared injecting equipment or paraphernalia during the 
previous month. The most-used sites of injection reported were: the arm, 174 (53%), and the groin, 91 (28%), with 81  
(25%) reporting using more than one site. 
Table 3 gives the profile of the cohort in terms of blood-borne viral infection status, testing and treatment, as reported by the 
participants. Among those who tested positive for HIV (22), hepatitis C (125) and hepatitis B (12), uptake of treatment was 
poor, being as low as 14% in the case of hepatitis C. Of those who tested negative for any BBV, and who responded to the 
question, more than half had been tested within the past year. While reported co-infections for hepatitis B and C (3%) and  
HIV and hepatitis C (6%) were low, 73% of those who were HIV positive were also hepatitis C positive. 
The research group involved in this study make recommendations in three main areas:
 ■ Policy – relating to needle exchange programmes, screening for BBVs, and ‘further consideration of safer injecting facilities 
in an Irish context …in future national policy deliberations’.
 ■ Research – relating to the specific needs of certain groups, including older, female and homeless users, polydrug users and 
steroid users, and the need for further research on needle-exchange services, serological testing and the management of 
hepatitis C.
 ■ Practice – relating to improving service access and use by female and migrant drug users, familiarising staff with the 
profile of polydrug and steroid use, developing collaborative relationships with external agencies to improve uptake of 
BBV testing and treatment, encouraging safer injecting workshops, and, particularly in the case of drug users who are 
homeless, greater integration of voluntary and statutory services in a multi-disciplinary case management approach that is 
client-centred.
(Martin Keane)
1. Jennings CJ (2013) Re-establishing contact: a profile of clients attending the Health Promotion Unit – needle exchange at Merchants 
Quay Ireland. Dublin: Merchants Quay Ireland. www.drugsandalcohol.ie/19914
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Table 2 Current use of substances reported by participants (N=338) 
Substance used in past month Males (n=290) Females (n=48)
n % n %
Heroin 249 86 41 85
Prescribed methadone 132 46 35 73
Cannabis 71 24 11 23
Alcohol 63 22 11 23
Illicit benzodiazepines 48 17 12 25
Prescribed benzodiazepines 42 14 11 23
Cocaine 25 9 0 0
Steroids 17 6 4 8
Mephedrone 16 6 5 10
Crack cocaine 16 6 4 8
Illicit methadone 7 2 1 2
Amphetamines 4 1 0 0
Other 7 2 6 13
Source: Jennings (2013)
Table 3 Blood-borne viral infection: reported status, testing and treatment 
Tested Positive Receiving 
treatment
Negative Time since last test taken by those 
with negative results 
No. of 
responses
<1 year >3 years
Total cohort 338 (100%)
Tested for HIV 264 (78%) 22 (8%) 10 (45%) 234 (89%) 198 109 (55%) 25 (13%)
Tested for hepatitis C 278 (82%) 125 (45%) 18 (14%) 140 (50%) 112 70 (63%) 14 (12%)
Tested for hepatitis B 263 (78%) 12 (5%) 2 (17%) 241 (92%) 204 106 (52%) 32 (16%)
Tested for co-infections
Hepatitis C and HIV 262 (78%) 15 (6%)
Hep B and Hep C 262 (78%) 8 (3%)
Hep B/Hep C/HIV 258 (76%) 1 (<1%)
Source: Data from Jennings (2013)
drugnet>
Ireland
32
Report of the Inspector of Prisons
The Inspector of Prisons in his annual report for 2012 stated 
that the availability of drugs remains a major issue in a 
number of prisons.1 In particular, he made reference to drug 
problems in Limerick Prison, a matter that was also raised by 
the Limerick Prison Visiting Committee in their annual report 
for 2012.2 The Inspector also identified a number of issues 
of concern throughout the prison system, many of them 
drug-related. At present, for example, approximately 25% 
of Irish prisoners are in secure 23-hour lock-up for their own 
protection. This is often linked to threats from drug gangs 
in prison or because of drug debts owed to individuals or 
gangs. According to the Inspector’s report:
The reasons why prisoners are on protection vary. In 
certain cases prisoners request that they wish to go on 
protection as they are either under direct threat from 
others in the prison or perceive that they are under 
threat. In other instances they are on protection simply 
because they come from a particular geographic area of 
the Country or because of their cultural ethnicity. The 
prevalence of gangs in the prison, which reflects that 
which is on the outside, is also a problem as vulnerable 
prisoners can be forced to join a gang or do so of their 
own volition as they perceive that by doing this they are 
safer. (p.13) 
One by-product of this prison reality is the undermining of 
drug service provision for dependent drug users in prison. 
The Inspector also points out that when prisoners are on 
23-hour lock-up they effectively have little or no contact with 
teachers or addiction services. 
(Johnny Connolly)
1. Reilly M (2013) Office of the Inspector of Prisons annual report 
2012. Nenagh, Co Tipperary: Office of the Inspector of 
Prisons. www.drugsandalcohol.ie/20341
2. Limerick Prison Visiting Committee (2013) Annual report 
2012. Dublin: Department of Justice and Equality.  
www.justice.ie/en/JELR/Pages/PB13000219
LRC calls for repeal of mandatory 
sentencing legislation in drug cases
The recent report published by the Law Reform Commission 
(LRC)1 recommends that the presumptive sentencing regime 
for drug offences be repealed.2 The Criminal Justice Act 
1999 created a new offence of possessing controlled drugs 
having a value of £10,000 (€13,000) or more for sale or 
supply, which attracted a presumptive sentence of 10 years’ 
imprisonment, except where there were ‘exceptional and 
specific circumstances’ relating to the offence, or to the 
person convicted of the offence. In an earlier consultation 
paper on the operation and impact of this legislation,3 the 
LRC called for a review of the sentencing regime, finding that 
in effect it had merely led to a ‘bulge in the prison system 
comprising low-level drugs offenders’ serving lengthy prison 
sentences (p.189). Following further examination, the LRC 
concludes in the present report that the legislation has not 
contributed to any reduction in levels of criminality, ‘the 
paramount aim of the criminal justice system’ (p.181).
This report reviews similar legislation in a number of 
other common law countries, noting that the enactment 
of presumptive minimum sentencing in Ireland was, to 
some extent, influenced by sentencing reforms in the US 
and the UK in particular. In the drugs context, a range 
of punitive sentencing measures has been introduced in 
other jurisdictions so as to reflect the relative seriousness 
of specific drug-related offences. Aggravating factors can 
include: repeat drug offences, dealing drugs to minors or 
‘with the aid or conspiring of a child under the age of 18 
years’ (p.155), drug trafficking while in possession of a 
firearm, selling drugs on a school bus or in the vicinity of a 
school, college, in a housing project, or to someone who 
is pregnant; running a drug trafficking enterprise or acting 
as the ‘principal administrator, organiser or leader of a 
continuing criminal enterprise’ (p.157) can also lead to more 
severe punishments. Aggravating factors may also relate to 
the quantity of drugs involved in the offence (p.161).
Although such a comparative analysis is of interest, the 
LRC cautions against relying too heavily on examples set 
by other countries, noting that these provisions ‘are often 
the product of circumstances and cultural factors specific 
to the jurisdiction in question’ (p.174). Ultimately, the LRC 
concludes, presumptive sentencing should be evaluated 
in terms of the extent to which it is consistent with the 
general aims of criminal sanctions, which include deterrence, 
punishment, reform, rehabilitation and reparation.4
Sections 4.191 to 4.197 of the report deal individually 
with these general aims (pp.174–176). In particular, the 
LRC observes that deterrence and punishment feature 
prominently as aims in respect of offences that attract 
presumptive sentences, as these sentences seek to
(i)  dissuade by coercive means, the offender from 
committing another drugs or firearms offence and 
to punish him or her severely for the offence that 
he or she has committed, and 
(ii)  dissuade the public at large from committing the 
relevant drugs or firearms offences. (p.174)
With regard to deterrence, the LRC observes that, in 
practice, ‘high-level [drug] offenders…shield themselves 
from detection and prosecution by means of complex and 
constantly evolving networks of distributors. It is unlikely 
that such offenders would be deterred by the prospect of 
a presumptive …sentence when they are unlikely to be 
subjected to it’. At the other end of the scale, offenders are 
either ‘low-level drug mules whose involvement in the drugs 
trade is generally secured by means of exploitation and/
or coercion’ or, referring to an observation of the Court of 
Criminal Appeal, ‘they are themselves drug addicts struggling 
to escape from the terrors of their addiction’. Drug mules 
would be unlikely to be deterred by a presumptive sentence, 
in many cases either not being equipped to assess the legal 
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consequences of their actions or fearing the consequences 
of refusing to carry drugs. Dependent drug users, on the 
other hand, are prepared to risk ‘victimisation, overdose, the 
transmission of diseases, and toxicity and impurities in the 
drug in order to feed their addiction’ and, as a consequence, 
according to the LRC, ‘they are unlikely to be deterred by the 
prospect of lengthy imprisonment’.
With regard to meeting the aims of punishment from a 
retributive perspective, the LRC highlights the apparent 
injustice inherent in the legislation whereby the same 
presumptive sentencing regime applies to individuals 
regardless of their position in the drug trafficking operation 
and their consequent level of moral culpability. This arises 
because ‘the market value of the drugs (€13,000 or more) 
…is prioritised at the expense of other factors relevant  
to culpability, such as role, motive and state of mind of  
the offender’.
In calling for a repeal of the presumptive sentencing 
regime, the LRC concludes that the objective of reducing 
drug-related crime is unlikely to be achieved solely through 
criminal law enforcement, and that crime-reduction 
approaches must be informed by a deeper understanding 
of the complexity of the relationship between illicit drug 
use and crime and a focus on measures aimed at addressing 
drug dependency.5
(Johnny Connolly)
1. The Law Reform Commission is an independent statutory 
body established by the Law Reform Commission Act 1975. 
Its principal role is to keep the law under review and to make 
proposals for reform, in particular by recommending the 
enactment of legislation to clarify and modernise the law.
2. Law Reform Commission (2013) Report: mandatory  
sentences. LRC 108–2013. Dublin: LRC.  
www.drugsandalcohol.ie/20242. The LRC uses the term 
‘presumptive’ as distinct from ‘mandatory’ in relation to 
sentences for certain drugs and firearms offences, in that 
there is a presumption that the sentence would apply 
unless the court deems otherwise in a specific case. The LRC 
distinguishes such sentences from mandatory life sentences 
for treason or capital murder, for example.
3. Law Reform Commission (2011) Consultation paper: 
mandatory sentences. LRC CP 66-2011.Dublin: LRC.  
www.drugsandalcohol.ie/16789. See also Connolly J (2012) 
Mandatory minimum sentencing. Drugnet Ireland, (41): 
23–24. www.drugsandalcohol.ie/17288
4. See detailed discussion in chapter one of the LRC 
conslutation paper. 
5. With regard to the drugs–crime linkage, the LRC report 
endorses the analysis provided by the Health Research 
Board in an earlier study: Connolly J (2006) Drugs and crime. 
Overview 3. Dublin: Health Research Board. It also highlights 
the current focus by the British–Irish Council on recovery 
from drug dependence. See discussion pp.176–177.
Research on recidivism
The Probation Service and the Central Statistics Office 
(CSO) established a partnership to conduct research on 
recidivism and related issues among offenders on supervision 
in the community. The report was published in November 
2012.1 The first of its kind in Ireland, the study was based 
on anonymised offender and offence information relating 
to a 2007 cohort of offenders on the Probation Service 
supervision database. The study reports on recidivism within 
two years among that cohort, and on a four-year follow-up 
based on recorded crime and Court Service data held by 
the CSO. The study also examines variations in recidivism 
relating to type of original order, gender and age of  
the offender, category of original offence and of the 
subsequent offence. 
The study provides an overview of community sanctions and 
their outcomes. The report lists some of its main findings:
 ■ Almost 63% of offenders on Probation Service 
supervision had no conviction for a further offence 
committed within two years of the imposition of a 
Probation or Community Service order. The overall 
recidivism of offenders in the study was 37.2%. 
 ■ Reoffending was twice as likely to occur in the first rather 
than the second twelve months. 
 ■ The recidivism rate decreased as offender age increased. 
 ■ Male offenders represented 86% of the total population 
and had a higher recidivism rate than female offenders. 
 ■ Public Order was the most common original offence and 
these offenders had the highest recidivism rate. 
 ■ The three most common offences for which offenders 
were reconvicted were the same as the three most 
common original offences: Public Order, Theft and 
Drugs. (p.2)
The Irish Prison Service (IPS), in partnership with the CSO, 
also published a report on recidivism rates among ex-
prisoners in Ireland.2 The report, published in May 2013, 
is a study of recidivism among 7,701 prisoners released on 
completion of a sentence in 2007, using re-conviction data 
up to the end of 2010. The study also assesses variations  
in recidivism based on the age and gender of the offender,  
as well as the category of both the original and  
subsequent offences. 
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The IPS study is not comparable to the Probation study 
described on the previous page, which was based on a 
two-year period for reoffending and excluded a number of 
offence types. However, while the Probation study showed a 
recidivism rate of 37.2% within two years of the imposition 
of a probation or community service order, the IPS study 
showed a recidivism rate of 58.3% within two years of the 
completion of a prison sentence. 
The IPS report sets out the findings of the study (pp.9–15), 
including the following:
 ■ The overall recidivism rate of offenders within three years 
was 62.3%.
 ■ Two thirds of re-offences occurred within six months of 
release. Over 80% of re-offending occurred within 12 
months of release.
 ■ Males made up 92% of the total population studied 
and had a higher recidivism rate than females (63% as 
opposed to 57%).
 ■ The recidivism rate decreased as the offender age 
increased. While 68.5% of those under 21 years of age 
re-offended, the rate fell to 38.6% for the 51–60-year  
age group.
 ■ The highest rate of recidivism was among those  
who had served a sentence for burglary and related 
offences (79.5%).
 ■ The most common offence for which offenders were  
re-convicted was Public Order (1,281 or 27%). 
 ■ Almost 27% were reconvicted of the same offence;  
more than 34% of theft offenders committed a further 
theft offence.
 ■ More than 20% of drug offenders committed a further 
drug offence. 
The report concludes with the unsurprising observation: 
For the majority of those incarcerated, similar 
criminogenic needs and risks exist. …Lack of 
employment, abuse of alcohol and drugs, anti-social 
attitudes and companions, emotional and personal 
difficulties, poor educational achievement, family 
problems and lack of housing. (p.18) 
The authors question whether it is reasonable, given the 
complexity of the problems many prisoners have, to expect 
the IPS or the criminal justice system to provide solutions 
in terms of reintegration. They conclude, ‘If we are to 
really succeed in reconnecting offenders back to their 
communities, then we must devise a model which involves 
a multiplicity of state, community and voluntary agencies 
working in partnership on behalf of individual communities 
to bring about real change’ (p. 19).
The IPS and the Probation Service, in partnership with the 
CSO, intend to jointly publish annual recidivism figures. 
Consistent with this new partnership approach, the services 
have agreed a joint service strategic plan for 2013–2015.3 
Included in this are measures aimed at enhancing sentence 
management from pre- to post-imprisonment in a way 
which will ‘facilitate improved prisoner outcomes’, and at 
enhancing the roll-out of the Community Return scheme 
(p.3). 
The Community Return scheme is a joint Probation Service 
and IPS initiative whereby selected prisoners are granted 
temporary release on condition they perform unpaid 
supervised work in the community. Prisoners serving 
sentences of between one and eight years who have 
completed at least half their sentence are eligible. According 
to the 2012 annual report of the Probation Service4: ‘A pilot 
programme commenced in October 2011 and a total of 
365 offenders were released on to the scheme between that 
time and the end of 2012’ (p.9). The scheme had a 90% 
compliance rate in 2012. By the end of 2012, 221 offenders 
had completed their allocated work, with approximately 
10% (37) being returned to custody for non-compliance. 
The scheme involves a ‘two-strike’ rule whereby, if offenders 
fail to attend or are late for work on two separate occasions, 
they are regarded as in breach of the rules governing the 
scheme and are returned to custody to complete the entire 
balance of their sentence. According to the Probation Service 
2012 annual report:4 
The experience of all concerned has been very positive 
and many Community Return participants have been 
commended for their work ethic, punctuality and 
commitment. Initial feedback from the participants 
has also been positive with many commenting on the 
supports and structure it gives them on their release 
and how it has assisted in their transition back into the 
community. (p. 9) 
(Johnny Connolly)
1. Probation Service (2012) Probation Service recidivism  
study 2007–2011. Dublin: Probation Service.  
www.drugsandalcohol.ie/20385
2. Irish Prison Service and Central Statistics Office (2013) Irish 
Prison Service recidivism study 2013. Dublin: Irish Prison 
Service. www.drugsandalcohol.ie/19942
3. Irish Prison Service and Probation Service (2013) Joint Irish 
Prison Service & Probation Service strategic plan 2013–2015. 
Longford: Irish Prison Service & Probation Service.  
www.drugsandalcohol.ie/19935
4. Probation Service (2013) The Probation Service annual report 
2012. Dublin: Probation Service. www.drugsandalcohol.
ie/19936
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Penal reform high on the agenda
A report on penal reform by the Joint Oireachtas Committee 
on Justice, Defence and Equality1 makes a number of 
recommendations aimed at reducing overcrowding in 
Irish prisons and promoting the development of effective 
alternatives to imprisonment. In October 2011, the Joint 
Committee established a sub-committee on penal reform, 
following publication of a report by the Thornton Hall Project 
Review Group.2 
The Thornton Hall Group considered the application of 
alternatives to custody from both front-door and back-door 
perspectives. Front-door strategies involve reducing the 
numbers sent to prison, while back-door strategies involve 
some form of early release. The Group’s report identifies  
(on p. 60) three forms of early release in Ireland:
 ■ the government power to commute or remit any 
sentence under Article 13.6 of the Constitution;
 ■ remission under the Prison Rules, which provide that 
prisoners can earn remission of up to 25% of their 
sentence; and
 ■ temporary release, provided for under the Criminal 
Justice Act 1960 as amended by the Criminal Justice 
(Temporary Release of Prisoners) Act 2003. 
The recommendations of the Joint Committee are aimed 
at enhancing these measures. Concerned about the 
‘significant increase over recent years in the number of 
prisoners in Ireland’, the Committee called, in an overarching 
recommendation, for ‘the adoption of a ”decarceration 
strategy”; a declared intention by the Government to reduce 
the prison population by one-third over a ten-year period’ 
(p.9). The Committee also recommended that all sentences 
of less than six months’ imprisonment imposed in respect 
of non-violent offences should be commuted and replaced 
with community service orders and that standard remission 
should be increased from one-quarter to one-third of all 
sentences over one month in length.
The Joint Committee also endorsed a recommendation 
made by the Irish Penal Reform Trust in its submission to 
the committee3 in calling for ‘a single piece of legislation 
which would set out the basis for a structured release system; 
to include proposed changes to remission…temporary 
release and parole. …for an expanded community return 
programme…[and to] underpin the strategies currently used 
by groups working with offenders post-release, and with 
potential offenders’ (p.9). Finally, the Committee highlighted 
the need to address poor prison conditions and prison 
overcrowding and it called for an increase in the number of 
open prisons.
(Johnny Connolly)
1. Houses of the Oireachtas Joint Committee on Justice Defence 
and Equality (2013) Report on penal reform. Dublin: Houses 
of the Oireachtas. www.drugsandalcohol.ie/19618
2. The Thornton Hall Project Review Group was established in 
April 2011 by the Minister for Justice and Equality to review 
proposals of the previous government to build a large prison 
called Thornton Hall in County Dublin. See: Project Review 
Group (2011) Report of the Thornton Hall Project Review 
Group. Dublin: Department of Justice and Equality.  
www.justice.ie/en/JELR/Pages/ThorntonHallReviewRpt
3. The Irish Penal Reform Trust is Ireland's leading non-
governmental organisation campaigning for the rights 
of people in prison and the progressive reform of Irish 
penal policy. See: Irish Penal Reform Trust (2012) Reform of 
remission, temporary release and parole. Dublin: Irish Penal 
Reform Trust. www.drugsandalcohol.ie/18656
Drug law enforcement and seizures
In a recent Dáil debate on Garda operations tabled by the 
Joint Oireachtas Committee on Justice, Defence and Equality, 
the Garda Commissioner stated that there are approximately 
25 organised crime groups (OCGs) operating throughout the 
state.1 The majority are centred in large urban areas such as 
Limerick, Cork, Galway, Sligo and Dublin. The Commissioner 
went on to say:
There is a high amount of interaction between the 
various organised crime groups throughout the  
country who regularly pursue joint enterprises, 
particularly drug imports. The vast majority of organised 
crime groups are drug trafficking groups… . … Each of 
these organised crime groups is structured hierarchically 
and would typically consist of a leadership, a number of 
middle-managers and low level criminals who could  
carry out day-to-day running of these organised crime 
groups. (p.4)
The 2012 annual report of the Garda Síochána2 states that 
the Garda National Drugs Unit (GNDU) liaises with police 
forces in the UK, Spain, Holland and Belgium, ‘where OCG’s 
affecting the Irish jurisdiction tend to be the most proactive’ 
(p.4). The GNDU has overall responsibility for drug law 
enforcement. In 2012, the GNDU arrested 125 people in 
connection with drug trafficking offences, 91 of whom were 
charged and are currently before the courts. Seventy-one 
‘significant seizures’ were made, including one in June 2012 
of 432kg of cocaine with an estimated street value of €30.23 
million, which was imported to Ireland from Bolivia via the 
Netherlands. Customs Drugs Law Enforcement and the US 
Drug Enforcement Administration were also involved in 
this operation. According to the 2012 annual report of the 
Revenue Commissioners, three members of an Irish OCG 
were arrested during this operation.3
Seizures of this size are, of course, untypical. The majority of 
drug seizures involve small amounts seized from individuals 
who possess the drugs for personal use. Drug seizures are 
primarily a reflection of law enforcement activity, with 
the number of seizures in any given period affected by 
such factors as law enforcement resources, strategies and 
priorities, and by the vulnerability of traffickers to those 
activities. However, drug seizure trends can also provide an 
indirect indicator of the supply and availability of drugs.
Cannabis seizures account for the largest proportion of all 
drugs seized. Figure 1 shows trends in cannabis-related 
seizures and total seizures between 2003 and 2012. The 
total number of drug seizures increased from 5,299 in 2004 
to a peak of 10,444 in 2007. Between 2008 and 2010 the 
number almost halved, to 5,477. This decrease can be 
drugnet>
Ireland
5Extent and patterns of cannabis use  
in Ireland
The National Advisory Committee on Drugs and Alcohol 
(NACDA) recently published Bulletin 3 in the series of 
reports on the 2010/11 survey on drug use in the general 
population in Ireland and Northern Ireland.1 The bulletin 
reports on cannabis use in the adult population (15–64 
years), on cannabis dependence and cannabis abuse as well 
as on patterns of cannabis use in Ireland. A total of 5,128 
people were interviewed, representing a response rate of 
60%. This article presents a summary of the main results for 
Ireland reported in the bulletin.
Key findings
Prevalence: use, abuse and dependence
The results from the 2010/11 survey reveal that 25% of the 
adult population (15–64 yrs) reported having used cannabis 
at some point during their lives (lifetime use); 6% reported 
use in the year prior to the survey (recent use); 3% reported 
use in the month prior to the survey (current use). 
The rates of cannabis use were notably higher among 
men than women. Lifetime prevalence for men (33%) was 
almost twice as high as the rate for women (18%); last-year 
prevalence was three times as high (men, 9% vs women, 
3%); and last-month prevalence was five times as high  
(5% vs 1%). The lifetime prevalence among men increased 
from 27% in the 2006/7 survey to 33% in the 2010/11 
survey, a statistically significant increase of 22%. There was 
a relatively small increase, from 17% to 17.5%, in women’s 
lifetime prevalence rates in the same period.
Rates of cannabis use were substantially higher among 
young adults (15–34 years) than among older adults  
(35–64 years) in the 2010/11 survey. Lifetime prevalence 
among young adults (33%) was more than one and a half 
times that among older adults (19%), last-year prevalence 
was just over three times as high (young adults 10% vs 
older adults 3%) and last-month prevalence was five times 
as high (5% vs 1%). While there were statistically significant 
increases in lifetime prevalence for younger adults, 
from 29% in 2006/7 to 33% in 2010/11, no statistically 
significant changes were found for older adults over that 
period (3% in both 2006/7 and 2010/11). 
The prevalence of cannabis abuse and of cannabis 
dependence were measured in the NACD Drug Prevalence 
Survey the first time in 2010/11 using M-CIDI,2 as advised 
by the European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). Substance abuse and substance 
dependence are defined by the DSM-IV as a maladaptive 
pattern of substance use leading to clinically significant 
impairment or distress. 
Seventeen per cent of recent cannabis users met the 
criteria for cannabis abuse, with rates being higher among 
males (20%) than females (8%) and among young adults 
(20%) than older adults (9%). Of the valid responses 
from the survey sample, 1.3% met the criteria for current 
cannabis abuse. Applying this rate to the 15–64-year-old 
general population (3,073,269 in 2011) we can infer that 
approximately 39,953 people in Ireland abuse cannabis. 
Nine per cent of recent cannabis users were classified as 
dependent. Dependence was higher among males and 
among young adults. Of the valid responses from the 
survey sample, 0.6% met the criteria for current cannabis 
dependence. Applying this rate to the 15–64-year-old 
general population, we can infer that approximately 18,440 
people in Ireland are cannabis dependent. 
Patterns of cannabis use
Among lifetime cannabis users, the median age of first use 
was 18 years. This was unchanged since the last survey. 
Almost half (48%) of the current cannabis users had used 
cannabis on 1–3 days (lowest frequency use) in the month 
prior to the survey, an increase on the 2006/7 figure of 
37%; this frequency was most common among female 
users (54%) and older adult users (55%). Between the two 
surveys the proportion of all adults engaging in the highest 
frequency use (20 days or more) in the previous month 
decreased from 24% to 14%.
Since 2006/7 the relative share of herb to resin used by 
current users has reversed. In 2010/11 herb was the main 
type of cannabis used by current users, at 71%, while resin, 
at 60%, was the most common form reported in the 2006/7 
survey. Almost all (94%) current cannabis users said that 
a joint was the main method they used when consuming 
cannabis. Forty-five per cent did not know where the 
cannabis they consumed was grown; 38% said that the 
cannabis they used was grown in Ireland, an increase on the 
2006/7 figure of 16%. 
Nearly three quarters (73%) of recent users said it would be 
easy for them to obtain cannabis in a given 24-hour period. 
Over four fifths (83%) said they sourced cannabis from 
someone they knew relatively well, e.g. either shared by or 
bought from family members and/or friends. 
Over one quarter (27%) of lifetime cannabis users said  
they had used it on a regular basis at some point and most 
(74%) of this group said they had stopped using. The three 
most common reasons given for stopping cannabis use 
were: not wanting to take it any more (27%); cannabis 
being no longer a part of their social life (18%); and health 
concerns (17%).
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From Drugnet Europe
Health and social responses profiles 
Cited from Drugnet Europe, No. 82, April–June 2013
How are countries in Europe responding to drug use in the 
areas of treatment, harm reduction, social reintegration and 
the prison environment? The EMCDDA’s country-by-country 
Health and social responses profiles (HSRs) aim to answer this 
question. The profiles include interactive maps and timelines 
showing the year in which key treatment and harm reduction 
measures were introduced in Europe. Also included are 
key source data and a glossary of terms. Available at www.
emcdda.europa.eu/countries/hsr-profiles
Perspectives on drugs
Cited from Drugnet Europe, No. 82, April–June 2013
The EMCDDA’s new Perspectives on drugs (PODs) are online 
analyses providing insights into a selection of important 
issues. Eleven PODs were released alongside the European 
Drug Report, covering as many issues, including: new 
treatment approaches for hepatitis C; high-risk cannabis use; 
cocaine-related emergencies; and the control of increasingly 
available new psychoactive substances. The PODs, which 
incorporate video and interactive features, offer key content 
in user-friendly summaries downloadable in pdf. Available at 
www.emcdda.europa.eu/topics/pods
Misuse of medicines in the EU
Cited from Drugnet Europe, No. 83, July–September 2013 
The misuse of medicines in Europe is an issue of growing 
concern. With studies revealing that analgesics, sedatives/ 
hypnotics and opioid substitution medicines are being 
consumed in ways other than those medically intended,  
this phenomenon merits greater awareness. 
In order to assess the severity and magnitude of the problem, 
experts from the EMCDDA and the German national focal 
point (IFT) carried out a systematic review of the literature 
on the misuse of these drugs (with the exception of 
benzodiazepines).1 Relevant literature was identified between 
2001 and 2011. The results show that the main groups of 
misused medicines include opioid analgesics, methadone, 
buprenorphine and the so-called Z-drugs (e.g. zopiclone, 
zaleplon, zolpidem). Regional trends in medicine misuse 
indicate heterogeneity across the EU with respect to misused 
medicine types and research activities. Prevalence, high-risk 
populations and factors contributing to medicine misuse are 
discussed in the review, as are the implications of the findings 
for prevention, treatment and policy in the EU. 
1. Casati, A, Sedefov R and Pfeiffer-Gerschel T (2012) Misuse of 
medicines in the European Union: a systematic review of the 
literature. European Addiction Research, 18(5): 228–245. 
New report reveals how a better understanding of  
the science of addiction can improve our response to 
drug problems 
Cited from Drugnet Europe, No. 83, July–September 2013 
Designed to encourage debate and promote understanding 
of the concept, [a new report from the EMCDDA] Models 
of addiction1 provides a critical review of existing addiction 
theories and explores how these can be organised into an 
overarching structure to inform how we assess, prevent 
and treat addictive behaviours. This is not limited to the 
traditional illicit drugs of abuse, but also covers alcohol and 
tobacco use and even non-pharmacological addictions, such 
as gambling or compulsive use of the Internet. 
The new report shows that there is no single model of 
addiction but competing perspectives sharing common 
elements. With this peer-reviewed analysis, the EMCDDA 
supports drug policy by providing a broad definition of the 
term, covering substance-based and behavioural addiction 
and reflecting current scientific developments.
An essential take-home message from the analysis is that, 
whilst there are advantages to be drawn from our growing 
understanding of the biological basis of addiction (e.g. ‘brain 
disease’ model), it is not helpful to be over reductive. The 
report argues that understanding the broader social and 
psychological aspects of addictive behaviour can also be 
important for successful prevention and treatment responses. 
It provides a basis for a more comprehensive and structured 
approach to developing responses and highlights the  
need to draw on a pool of interventions (education, 
persuasion, training). 
1. West R (2013) Models of addiction. EMCDDA Insights Series 
No. 14. Luxembourg: Publications Office of the European 
Union. www.emcdda.europa.eu/publications/insights/
models-addiction
Drugnet Europe is the quarterly newsletter of the 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). Drugs in focus is a series of policy 
briefings published by the EMCDDA. Both publications 
are available at www.emcdda.europa.eu.
If you would like a hard copy of the current or future 
issues of either publication, please contact:
Health Research Board, Knockmaun House,  
42–47 Lower Mount Street, Dublin 2. 
Tel: 01 2345 148; Email: drugnet@hrb.ie
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Recent publications
Journal articles
The following abstracts are cited from recently published journal 
articles relating to the drugs situation in Ireland.
Onset of cocaine use: associated alcohol intoxication 
and psychosocial characteristics among adolescents in 
substance abuse treatment
Apantaku-Olajide T, Darker CD and Smyth BP
Journal of Addiction Medicine, 2013, 7(3): 183–188.
www.drugsandalcohol.ie/20340
Objectives: Cocaine abuse is widespread in Europe, and Ireland 
ranks among the leading countries for prevalence of cocaine use 
among adolescents. This study aimed to examine demographic 
and substance use correlates of lifetime cocaine use among 
adolescents with substance use disorder, and to explore the 
relationship between alcohol intoxication and cocaine initiation. 
Methods: Data from a cross-sectional study of 171 adolescents 
presenting to an outpatient substance abuse treatment program 
in the Dublin metropolitan area were analyzed. Bivariate and 
multivariate analyses were conducted. 
Results: Approximately 64% of the participants reported ever 
having used cocaine: 70% reported the first use of cocaine was 
while alcohol intoxicated and 96% reported the onset of cocaine 
use was preceded by cannabis use. Later age at treatment entry, 
unstable accommodation, non engagement in educational/
vocational functions, and greater frequency of alcohol and 
cannabis use had robust associations with lifetime cocaine use. 
Male gender was significantly associated with first use of cocaine 
while alcohol intoxicated. 
Conclusions: Alcohol frequently plays a central role in cocaine 
initiation in Irish adolescents. Efforts to delay, avoid, or reduce 
adolescent drinking may yield benefits in terms of reducing 
cocaine use initiation in this population.
A qualitative study of prescribing doctor experiences of 
methadone maintenance treatment
Van Hout MC and Bingham T 
International Journal of Mental Health and Addiction, 2013, 25 
April, Early online.
www.drugsandalcohol.ie/20262
Methadone maintenance treatment (MMT) is recognized as 
an effective treatment for opiate dependence. It is provided in 
Ireland in addiction clinics and for stabilized patients in primary 
care. The aim of the study was to explore doctor’s experiences 
of methadone prescribing, therapeutic alliance and methadone 
treatment pathways. Semi structured interviews were conducted 
with a convenience sample of prescribing doctors (n = 16). 
Thematic analysis of narratives was undertaken. Observations 
around MMT were positive in reducing harm associated with 
injecting drug use and opiate dependence, and represented 
an important turning point for patients. Doctor efforts to assist 
their patients were grounded in positive, empathic relationships. 
Some concerns were relayed with regard to prescribing 
restrictions. Participants commented on the need for policy 
makers to consider the expansion of MMT provision to include 
alternative pharmacological approaches, improved interagency, 
psychosocial and detoxification supports, community based 
nurse prescribing and adjunct treatment for polydrug and 
alcohol use.
Miaow miaow: a review of the new psychoactive drug 
mephedrone
Brennan R and Van Hout MC
Drugs and Alcohol Today, 2012, 12(4): 241–253.
www.drugsandalcohol.ie/20261
Mephedrone is a synthetic stimulant drug causing entactogenic 
and hallucinogenic effects. A systematic review of all existing 
empirical research and literature from 2009 to 2012 on this new 
psychoactive drug was conducted. This paper aims to report on 
that review. The search was restricted to publications from 2009 
to 2012, and produced 702 results; 598 results were discarded, 
with 104 deemed suitable for inclusion.
The review underscores mephedrone's popularity despite 
legislative controls. Drug displacement patterns from illicit to licit 
were observed prior to controls, with blending of mephedrone 
and other substitute cathinones with street drugs thereafter. User 
consumptive choices are grounded in availability, perceptions 
of legality and safety, curiosity and perceived quality of drug 
outcomes within poly drug taking repertoires. Clinical reports 
indicate that mephedrone has high abuse potential and toxicity, 
with several dependence symptoms. Risk assessment, detection, 
diagnosis and treatment of mephedrone use are difficult due  
to polydrug use and associated mental health disorders. 
The review points to the need for further research into the 
pharmacology and toxicity of mephedrone in order to better 
equip clinicians with assessment, diagnosis and treatment 
strategies to reduce morbidity.
Methadone, codeine and acute haemorrhagic necrotising 
pancreatitis: which came first?
Tormey WP, Sabah M and Moore TM 
Forensic Science International, 2013, 226(1–3): e52–53.
www.drugsandalcohol.ie/20240
Acute haemorrhagic necrotising pancreatitis led to the death at 
home of a young female who was on a methadone maintenance 
programme. Toxic levels of codeine with potentially lethal 
levels of methadone and morphine were found at post-
mortem. Whether opiates caused the pancreatitis or were 
the consequence of self-medication for pain is impossible to 
differentiate. Forensic toxicology may pose the question but  
be unable to provide the answer.
Teachers' perspectives on their role in school-based 
alcohol and cannabis prevention
Van Hout MC, Foley M, McCormack A and Tardif E 
International Journal of Health Promotion and Education, 2012, 
50(6): 328–341.
www.drugsandalcohol.ie/20235
Schools are an important setting for the implementation of 
health education and harm prevention initiatives. 
The research aimed to investigate teachers’ perspectives in 
Ireland on their role and that of the school in the delivery of 
school-based alcohol and cannabis education–prevention. Irish 
school-based drug education–prevention is currently provided 
within the remit of the Social Personal Health Education (SPHE) 
module. Thirteen second-level schools took part in the research. 
A questionnaire collected information on teachers’ experiences 
of student alcohol and cannabis use, attitudes toward teacher 
and school prevention roles, and levels of school satisfaction 
(n = 131). The results indicated that teachers’ experiences of 
effects of student alcohol and cannabis use in school were 
rare. Over half of teachers had never taken part in education 
or prevention activities, with SPHE teachers more likely to do 
so and report a positive attitude toward such activities. Teacher 
levels of satisfaction with their school were positively correlated 
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with attitude toward the teacher and school's role in alcohol 
and cannabis education–prevention. High awareness of school 
drug and alcohol policies was recorded, along with the need for 
training, support, and information for all teachers. The findings 
underscore the need for ‘whole school’ integrated approaches 
involving a shared organisation-wide approach to student 
substance education–prevention.
Using chi-Squared Automatic Interaction Detection 
(CHAID) modelling to identify groups of methadone 
treatment clients experiencing significantly poorer 
treatment outcomes
Murphy E and Comiskey C
Journal of Substance Abuse Treatment, 2013, 45(4): 343–349.
www.drugsandalcohol.ie/20187 
In times of scarce resources it is important for services to 
make evidence based decisions when identifying clients with 
poor outcomes. Chi-Squared Automatic Interaction Detection 
(CHAID) modelling was used to identify characteristics of clients 
experiencing statistically significant poor outcomes. A national, 
longitudinal study recruited and interviewed, using the Maudsley 
Addiction Profile (MAP), 215 clients starting methadone 
treatment and 78% were interviewed one year later. Four CHAID 
analyses were conducted to model the interactions between 
the primary outcome variable, used heroin in the last 90 days 
prior to one year interview and variables on drug use, treatment 
history, social functioning and demographics. Results revealed 
that regardless of these other variables, males over 22 years of 
age consistently demonstrated significantly poorer outcomes 
than all other clients. CHAID models can be easily applied 
by service providers to provide ongoing evidence on clients 
exhibiting poor outcomes and requiring priority within services.
Problem alcohol use among problem drug users: 
development and content of clinical guidelines for 
general practice
Klimas J, Cullen W and Field CA 
Irish Journal of Medical Science, 2013, 3 July, Early online.
www.drugsandalcohol.ie/20158 
Problem alcohol use is common and associated with 
considerable adverse outcomes among patients who attend 
primary care in Ireland and other European countries for 
opiate substitution treatment. This paper aims to describe 
the development and content of clinical guidelines for the 
management of problem alcohol use among this population.
The guidelines were developed in three stages: (1) identification 
of key stakeholders, (2) development of evidence-based draft 
guidelines, and (3) determination of a modified ‘Delphi-
facilitated’ consensus among the group members. They 
incorporate advice on all aspects of care, including (1) definition 
of problem alcohol use among problem drug users, (2) 
alcohol screening, (3) brief intervention, and (4) subsequent 
management of patients with alcohol dependence. The 
researchers concluded that primary care has an important role 
to play in the care of problem alcohol use among problem drug 
users, especially opiate substitution patients. Further research  
on strategies to inform the implementation of these guidelines  
is a priority.
Problem alcohol use among problem drug users in 
primary care: a qualitative study of what patients think 
about screening and treatment
Field CA, Klimas J, Barry J et al.
BMC Family Practice, 2013, 14:98
www.drugsandalcohol.ie/20447
Background: Problem alcohol use is common and associated 
with considerable adverse outcomes among patients who attend 
primary care in Ireland and other European countries for opiate 
substitution treatment. This paper aims to describe patients’ 
experience of, and attitude towards, screening and therapeutic 
interventions for problem alcohol use in primary care. 
Methods: This qualitative study recruited problem drug users 
(N = 28) from primary care based methadone programmes in 
the Ireland’s Eastern region, using a stratified sampling matrix 
to include size of general practice and geographical area. 
Semi-structured interviews were conducted and analysed using 
thematic analysis, and audited by a third reviewer. 
Results: We identified three overarching themes relevant to 
the purpose of this paper: (1) patients’ experience of, and 
(2) attitude towards, screening and treatment for problem 
alcohol use in primary care, as well as their (3) views on service 
improvement. While most patients reported being screened for 
problem alcohol use at initial assessment, few recalled routine 
screening or treatment. Among the barriers and enablers to 
screening and treatment, patients highlighted the importance 
of the practitioner-patient relationship in helping them address 
the issue. Nevertheless, patients felt that healthcare professionals 
should be more proactive in the management of problem 
alcohol use at a primary care level and that primary care can play 
an important role in their treatment. 
Conclusions: Problem alcohol use is an important challenge in 
the care of problem drug users. While primary care is well placed 
to address this issue, little data has reported on this topic. The 
development of interventions which promote screening and 
brief interventions in practice are likely to benefit this at-risk 
group and further research and education, that help achieve this 
goal, are a priority. Strategies such as dissemination of clinical 
guidelines, educational videos, academic detailing and practice 
visits, should be explored. 
Substance use in young persons in Ireland, a systematic 
review
Murphy K, Sahm L, Lambert S and Byrne S 
Addictive Behaviors, 2013, 38(8): 2392–2401.
www.drugsandalcohol.ie/19669
Adolescence is a time of physical and mental development when 
small changes can impact on the rest of a person's life. Substance 
use in this crucial period can have long-lasting consequences for 
the individual and for society. The prevalence of substance use in 
young people is an area of concern for policy makers and health 
workers. This systematic review looked at prevalence for four 
substances, alcohol, tobacco, cannabis, and benzodiazepines, 
across the Republic of Ireland for persons between the ages of  
13 and 24, and compared usage between 2000 and 2012. 
Eighteen articles were included in the review. It was seen that 
tobacco, alcohol, and cannabis use has fallen in the lifetime 
and previous month use. The level of benzodiazepine use has 
remained similar in the period of study. Future work should 
redress the imbalance in substance use research that sees the 
majority of researchers looking at a few substances while little 
work is done on the others.
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Upcoming events
(Compiled by Joan Moore – jmoore@hrb.ie) 
October
10 October 2013
Drugs and alcohol in the workplace  
– assessment, treatment and rehabilitation 
 34th annual EAP conference
Venue: Ashling Hotel, Parkgate Street, Dublin 8
Organised by / Contact: EAP Institute
Email: anita@eapinstitute.com
Web: www.eapinstitute.com/conference13/conference.asp
Information: This conference will feature presentations from HR 
managers, medical specialists, experts in toxicology and laboratory 
drug testing, EAP consultants and community based support groups 
on resources available to those in the workplace who may require 
assessment, treatment and rehabilitation. The invited speakers are: Prof 
Aidan McCormick, St Vincent’s Hospital; Pat Ward, head of corporate 
services, Dublin Port Company; Maurice Quinlan, director of the EAP 
Institute; Dr Mark Piper, toxicology manager, Randox Testing Services; 
Invited speakers from Alcoholics Anonymous, Narcotics Anonymous and 
Al-Anon Family Services. Session chairs are Frank Cunneen, IBEC, and 
Alan Moran, Hibernian Healthcare. 
10 October 2013
Drugs & Alcohol – over the counter, under the net 
One-day training course
Venue: Easton Business Centre, Bristol BS5 0HE
Organised by / Contact: The Training Exchange
Email: info@trainingexchange.org.uk
Web: http://tinyurl.com/blo4fry
Information: Drugs bought over the counter in chemists and via the 
internet are now commonplace. But what kind of a problem are they? 
Explore the changing face of drug-using culture, the commercialisation 
of medications, and the revolutionary impact of the internet and how 
it is policed. This course provides opportunities to identify the drugs 
available, how much we know about them, their effects and risks; and 
to consider how we can work effectively with people to reduce harm 
and support recovery. Trainer – Rowan Miller. 
19 October 2013
Family Support Network annual work conference
Venue: Citywest Hotel, Saggart, Co Dublin
Organised by / Contact: Family Support Network
Email: info@fsn.ie
Web: www.fsn.ie/news_events/index.html
Information: The National Family Support Network is an autonomous 
self-help organisation that respects the lived experiences of families 
affected by drugs in a welcoming non-judgemental atmosphere.  
The Annual Work Conference provides family support groups with  
the opportunity to discuss national policy and to participate in  
training workshops. See our website for more information on cost  
and what is included. Full payment along with completed booking  
form must be submitted to the NFSN by 20th September 2013 to 
guarantee your place.
November
7 November 2013
Pathways through prostitution: Exploring positive support 
models for women affected by prostitution and sex trafficking
Venue: Morrison Hotel, Ormond Quay Lower, Dublin 1
Organised by / Contact: Ruhama
Email: admin@ruhama.ie
Web: www.ruhama.ie/index.php
Information: This free half-day event will host presentations and 
sessions featuring: international research on exiting prostitution and 
recovery from sex trafficking; Ruhama’s model of work with women 
in Ireland; current trends, challenges and good practice responses; 
personal perspectives and needs of survivors; facilitated discussion. 
Full details of speakers will be posted on our website in due course. 
This event will be of interest to members of organisations working 
with vulnerable women, providers of migrant support, addiction and 
homeless services, and health, legal and law enforcement professionals. 
Registration is essential and numbers are strictly limited.
7–8 November 2013
SSA Annual Symposium 2013
Venue: Park Inn Hotel, York, UK
Organised by / Contact: DrugScope 
Email: Society for the Study of Addiction
Web: www.addiction-ssa.org/ssa_10.htm
Information: Professor Robert West will give the Society lecture: 
‘What can the experience of combating tobacco addiction globally 
tell us about better ways of addressing other addictions?’ Themes of 
the symposium will be: patient/service-user invovlement; effective 
mechanisms of treatment; alcohol and drug testing methods and their 
uses; international treatment and prevention policy. The winner of 
the SSA Fred Yates prize 2013, Jaime Delgadillo, will talk on his work, 
‘Mental health screening and outcome measurement in alcohol and 
drug users’.
11–16 November 2013
Drug and Alcohol Awareness Week
Organised by / Contact: Midland Regional Drugs Task Force
Email: mrdtf@hse.ie
Web: www.mrdtf.ie/news-details.php?ID=24
Information: Details will be posted on the MRDTF website in  
due course.
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